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ABSTRACT 
DISSECTING THE HISTONE-BINDING MECHANISM OF A PHD FINGER 
SUBTYPE 
DANIEL BOAMAH 
2017 
 
          Disordered tails of histones are critical information retrieval hub and thus, 
aberrations in the flow of information through these hubs are associated with a number of 
pathological consequences in human. Mechanism for retrieval of information from these 
hubs is achieved by protein-protein interaction, i.e. proteins dock onto histone tails to 
initiate chromatin signaling. Eukaryotes have a number of small peptide binding domains 
that have evolved to specifically interact with histone tails, and these domains called 
histone readers as they read the information encoded on histone tails.  Plant 
homeodomain (hereafter PHD) finger, a binucleated zinc finger, family is one such 
histone readers. Next-generation sequencing efforts on diagnosed patient’s genomes or 
cancer tissues show that mutations in PHD finger, particularly a subgroup of PHD 
fingers, are associated with number of pathological consequences. Therefore, for future 
understanding of the possible mechanisms for the pathological consequences, as an initial 
step, detailed characterization of the binding mechanism of the PHD subtype, the 
PHD_nW_DD, was undertaken here. Starting with human BAZ2A (bromodomain 
adjacent to zinc-finger 2A), one member of the PHD_nW_DD subtype that is associated 
with prostate cancer was utilized to probe the effect of mutations on histone tail binding. 
          We experimentally discovered two categories of mutations that disrupt peptide 
binding: (1) Type-A: positions that are in contact with the peptide and (2) Type-B: 
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positions that are remote from the peptide-binding site (distal site). For my dissertation, I 
focused on understanding the biochemical basis of the effects of Type-A mutations using 
recombinant protein chemistry and biophysical chemistry.  
          The peptide-anchoring residue positions of BAZ2A-PHD, interestingly, are 
enriched in specific type of residues in a subtype specific manner. The energetics 
revealed that, two non-polar amino acid residues and an Aspartate residue in the treble 
clef knuckle make significant contributions to the formation of the hBAZ2A-histone 
peptide complex as mutations at these three positions completely aborted peptide binding. 
The energetic contributions of the identified positions were further confirmed by 
mutagenesis in three members of the subtype (UHRF1-PHD, KDM5B-PHD and 
KAT6A-PHD) that included pairs sharing even less than 40% sequence identity with 
each other. Despite low sequence similarity, mutations cause similar consequences in 
histone H3 binding suggesting a strong similarity in the binding mechanism, and thus 
justifying the subtype classification.
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CHAPTER I 
                                             INTRODUCTION 
1.1. General Introduction 
          Structure dictates functions, and thus, the protein fold (the precise arrangement of 
the secondary structures in space) is intricately related to the function a protein performs. 
A protein fold is often also associated with a large sequence space meaning that several 
different sequences including diverse ones, that retain a few common sequence features, 
can adopt the same structural fold1-3. However, the precise biochemical function of 
diverse sequences, despite retaining the same overall fold can significantly differ from 
one another. Many protein folds are referred to as superfamilies for the diverse sequences 
they contain and the diverse biochemical functions they perform.  
          Plant HomeoDomain (PHD), a binucleated Zn finger4-6, is one such superfamily 
where the median sequence identity (in 85% non-redundant set)7 is only ~27%, i.e. 
diverse sequences populate the PHD fold. Although the primary biochemical function of 
PHD finger is to bind histone peptides, they can recognize different histone peptides. A 
correlation between the sequences of the histone peptide and sequences of PHD finger 
has been noted earlier7, 8 meaning that there are different subtypes of sequences within 
the PHD superfamily with each subtype capable of recognizing a distinct histone 
sequence. Thus, correlating the energetic contributions of the binding-site residues of 
PHD subtypes in the sequence specific interactions with histone peptides would be 
valuable for sequence-based classification of PHD fingers. The classification will be very 
useful in the genome-wide functional annotation of PHD finger sequences. In addition, 
detailed information of the energetic contributions of PHD residues will be useful for 
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manipulating the binding behavior of PHD by residue substitution, and this in turn can be 
useful for manipulating gene regulatory mechanisms, and then enable probing pathway 
specific flow of epigenetic information. 
          For this dissertation, we thus focus on PHD, particularly a specific subtype of the 
PHD finger. In general, PHD finger contains approximately 50-80 amino acid residue4-6 
with a characteristic cross-braced topology having two zinc atoms coordinated by one 
Histidine and seven cysteine residues within a Cys4-His-Cys3 sequence motif8 (Figure 
1.1)7, 9. PHD finger was discovered in the protein HAT3.1 in Arabidopsis thaliana in 
19936, 10. Most of the proteins with PHD fingers are found in the nucleus11, 12 because 
they are mainly involved in the modification of chromatin as well as the mediation of 
molecular interactions in gene transcription6, 8, 11, 13. They may occur as a single finger but 
can often be seen in cluster of two (Figure 1.2)7, 9 or more, and can also occur in tandem 
with other domains, such as bromodomain and chromodomain6, 8, 12, 14. 
           Earlier discovery of their function in chromatin regulation showed that they bind 
methylated-lysine histone H314-17. However, recent studies have shown them to have a 
sophisticated ability to recognize other sequences of histones, including histone peptides 
lacking post-translational modification (e.g., unmodified histones)7, 8, 18, 19. These studies 
reinforce that they are versatile in their ability to recognize histone sequences (modified 
and unmodified) in their role as epigenome readers that control gene expression by 
recruiting transcription factors and chromatin regulators7-9, 18, 19.  
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Figure 1.1.  A topological diagram of the PHD fold: The Cys and His residues hold the binucleated Zn 
atoms. A subtype that we study here has two Aspartate residues in the treble clef knuckle. The pair of Asp 
residues is noted to anchor the Arg2 of Histone H3 peptide. 
 
 
          The Zn-chelating Cys and His residues in many Zn-fingers (e.g., PHD finger, 
RING finger, FYVE finger etc.) appear with a characteristic 3D pattern called treble clef. 
The treble clef 3D motif 20 refers to a combination of a knuckle and a helix (Figure 1.1). 
In the treble clef motif, the knuckle provides two cysteine residues and the N-terminal of 
the helix provides the other two Zn-chelating cysteine residues for chelating the Zn atom.         
          Many domains or folds contain treble cleft motif and PHD finger is one of them. 
Many of these domains or folds (e.g., PHD finger, RING finger, FYVE finger etc.), in 
addition to possessing the treble clef motif, can have other secondary structural element 
that distinguish them from one another. For the discussion of this dissertation we often 
refer to treble cleft portion of the PHD finger and our entire study is about PHD finger 
(and not any other treble clef containing domains or folds).  
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Figure 1.2. Alignment of tandem PHD-PHD sequences as reported in Chakravarty et al., 2015. The zinc 
chelating positions are shown in green, red bar shows the presence of Aspartate residues and the gray bar 
shows the absence of Aspartate residues. 
 
          The treble clef portion of some of the PHD fingers have been reported to possess a 
pair of Asp residues7 that can interact with the Arg2 of the Histone H3 peptide. This 
characteristic pattern of Aspartic acid residue within the treble clef knuckle has been 
shown to be a subtype-specific property7 and the pair of Asp residues make a significant 
energetic contribution to the formation of the protein-peptide complex7. However, it is 
not clear if the presence of the treble clef Asp residues in the PHD sequences is enough 
for histone peptide binding. It is likely that other amino acid residues in the PHD 
sequence also make large contributions to the energetics of the protein-peptide complex 
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formation. In this, I wanted to identify the characteristics of those residues that make 
large energetic contributions for anchoring the H3 peptide. In addition, I wanted to 
determine if there are residues remote from the binding site that also contribute to peptide 
binding as this provides an opportunity to modulate binding by manipulations without 
altering the binding site. For this dissertation, therefore, I discuss histone-binding 
mechanism of PHD finger subtype in the context of energetic contributions of PHD 
subtype specific residues. 
 
1.2. Introduction to research 
          Protein-protein interaction on the chromosomes decisively contributes to the 
interpretation of the information encoded in the genome, and the tethering of proteins 
onto the intrinsically disordered tails of histones is a critical component of the 
chromosomal protein-protein interactions. Regulatory protein complexes, bound onto 
histone tails, are known to orchestrate chromatin-signaling pathways, which collectively 
regulate chromatin structure and thereby exert ultimate control over all the diverse 
biological outcomes associated with chromatin21, 22. Eukaryotes have evolved peptide-
anchoring scaffolds (typically called readers)23 to specifically recognize histone peptide 
segments24-27. In general, the disordered peptide segments of histone tails provide the 
binding surface for readers (present within the regulatory protein complexes) to facilitate 
the anchorage of regulatory complexes onto the chromatin.  
          Over the past decade, fascinating discoveries on the mechanisms of histone peptide 
recognition, revealed by high-resolution structures of readers in complex with cognate 
peptides24-27 are helping us to understand chromatin regulatory mechanisms in much 
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greater detail. For example, structures of histone recognition are providing important 
starting points to further probe detailed pathway-specific molecular mechanisms (e.g. 
Reengineering readers to switch their specificity for probing and altering DNA 
methylation landscapes in living stem cells)28, 29. 
          Opposed to de novo design, reader reengineering involves manipulation of a few 
binding site residues of an existing reader leaving the rest of the reader sequence 
unaltered28, 29. Therefore, structure guided dissection of the key determinants of histone 
peptide recognition mechanisms will continue to play important role not just in probing 
chromatin-signaling mechanisms but also in the design of reagents for diagnostic 
applications30, 31. Motivated by the application outcomes, our lab had earlier probed the 
energetics of the recognition of histone H3 N-terminal peptide by readers belonging to 
the same structural scaffold, the plant homeodomain (PHD)-finger, that recognize the 
same peptide sequence7.  
          The study revealed that recognition mechanisms could differ in the readout of the 
same peptide sequence by readers of even the same scaffold. It was also noted that the 
energetic contributions of the peptide amino acids correlated with the sequence features 
of the readers. For example, H3 Lys4 makes negligibly small energetic contributions 
towards N-terminal H3 recognition by PHD readers featuring a treble clef xCDxCDx 
motif, while H3 Lys4 makes a substantial energetic contribution for readers lacking the 
motif7. This lead to speculate that subtype specific sequence patterns for readers evolved 
for distinctly interacting with even the same peptide sequence, and a comprehension of 
the roles of all subtype specific sequence features would be invaluable to manipulate a 
reader’s substrate preferences for the above applications. Therefore, here, we investigate 
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the contributions of the subtype specific features of readers using the treble clef 
xCDxCDx motif featuring PHD subtype as a model to better understand histone-
anchoring adaptations. 
          PHD-finger of BAZ2A (bromodomain adjacent to zinc finger domain protein 2A), 
one of the xCDxCDx motif featuring readers was chosen as the base member for a 
detailed investigation of the peptide anchoring mechanism for the following reasons. 
BAZ2A, a subunit of the chromatin remodeling complex NoRC (nucleolar remodeling 
complex)32, possesses the PHD-Bromodomain cassette for facilitating chromatin 
anchorage of NoRC33, 34 for rDNA silencing35, 36. Likely for its critical role, BAZ2A 
overexpression is tightly associated with prostate cancer 37, where BAZ2A, along with 
EZH2 (enhancer of zeste homolog 2), coordinates epigenetic silencing in prostate cancer 
cells37. Thus, the possibility of therapeutically targeting BAZ2A chromatin anchoring 
scaffold has also been suggested37, and we, therefore, dissect the binding characteristics 
of BAZ2A-PHD.  
          The recent structure of the BAZ2A-PHD in complex with histone H3 N-terminal 
peptide highlights the role of acidic patch, another subtype specific feature, in peptide 
recognition38, suggesting the importance of recognizable sequence features in the 
functional characterization of readers. This work thus complements the structural report 
as we investigate a number of other sequences features, in addition to the acidic patch, 
not only in BAZ2A but also in several other readers. Initiated with BAZ2A-PHD, we 
follow up the probing of position specific contributions of residues using four additional 
readers (sharing low sequence similarity with BAZ2A-PHD). Based on an experimental 
analysis of a set consisting of a total of 29 proteins (5 wild type readers and their 24 
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mutants), we provide a comprehensive view of histone peptide recognition by a reader 
subtype. 
         The versatile canonical PHD binding-site8, like the versatile PDZ domain binding-
site39, 40, binds terminal peptides (e.g., the N-terminal H3) predominantly by beta 
augmentation41, and therefore , comparison of the binding mechanisms between the two 
is natural. The extensive work on PDZ binding mechanisms probed by large-scale 
mutagenesis40, sequence randomization42, and proteomic scale binding analysis43, 44 have 
been complemented by computational studies to extract correlation between PDZ 
binding-site positions45 for an evolutionary view on the origin of PDZ subtypes and 
binding versatility. Although the number of mutations considered in this study is 
comparatively much smaller than the hundreds of mutations used in the PDZ40 binding 
mechanism study, the results obtained using a reasonable size of the PHD proteins 
studied here, encouraged us to similarly probe the relationship between PHD binding-site 
positions by computational approaches here for a view on nature’s design principles of 
versatile binding-sites. In addition, the experimental binding thermodynamics observed 
here also encourages us to computationally analyze natural adaptations for anchoring 
histone tails, as these peptides lack the common peptide hotspot residues (W, Y, F, L and 
I)46. Overall, we provide a case-specific study of histone-reader interactions in the 
context of: (a) superfamily subtype characterization, (b) evolutionary relationship 
between positions of versatile binding-sites and (c) general adaptations for anchoring 
onto unmodified histone tails. 
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CHAPTER II 
 
ENERGETICS OF THE INTERACTIONS BETWEEN HUMAN BAZ2A-PHD 
FINGER-HISTONE H3  
 
 
ABSTRACT 
           PHD-finger of BAZ2A (bromodomain adjacent to zinc-finger 2A) protein is a 
histone H3 N-terminal peptide reader that uses the treble clef xCDxCDx motif for the 
recognition of the peptide. It is overexpressed in prostate cancer. The possibility of 
therapeutically targeting BAZ2A chromatin-anchoring scaffold for the metastatic 
potential of prostate cancer has recently been suggested37. Though some work has been 
done on the molecular mechanism as to how this protein interacts with the histone H3, 
the energetics involved in the interaction is lacking. As an initial step for the 
understanding of the possible mechanisms and the energetics, detailed characterization of 
the binding mechanism of the BAZ2A-PHD was undertaken. 
           Here, we have performed systematic site-specific mutagenesis in the recombinant 
version of this PHD finger, purified mutant proteins and measured interaction affinity 
between the mutant proteins and histone H3 using ITC (Isothermal Titration 
Calorimetry). We show that, two categories of mutations disrupt peptide binding: (1) 
Type-A: positions that are in contact with the peptide and (2) Type-B: positions that are 
remote from the peptide-binding site (distal site). For this dissertation, we focused on 
understanding the biochemical basis of the effects of Type-A mutations.  
The peptide-anchoring residue positions of BAZ2A-PHD making large energetic 
contributions are enriched in specific amino acids (bulky non-polar and acidic). The 
bulky non-polar amino acid residues identified here are Leu-1692 and Leu-1693 and are 
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tightly packed with the small side chains of the histone peptide. An Aspartate residue in 
the treble clef knuckle, Asp 1695, also makes significant energetic contribution to the 
formation of the hBAZ2A-histone peptide complex. Ala substitutions at these positions 
mentioned above completely aborted peptide binding. 
The recognition features identified here could be exploited in the PHD-finger subtype 
possessing the same scaffold and possibly utilized to develop peptide diagnostics for 
epigenome. 
 
INTRODUCTION 
          The human Bromodomain Adjacent to Zinc finger 2A (BAZ2A) also called TIP5, 
is a part of the chromatin remodeling complex NoRC (nucleolar remodeling complex) 
known to be involved in epigenetic rRNA gene silencing37, 47.  BAZ2A regulates 
numerous protein-coding genes and directly interacts with EZH2 to maintain epigenetic 
silencing at genes repressed in metastasis37. BAZ2A is a very large multidomain protein 
of a molecular weight of 211kDa and consists of a number of DNA and protein 
interaction domains33, 47. The protein contains a DNA binding homeobox and different 
transcription factors, methyl-CpG-binding domain, AT-hook DNA –binding domains, 
and a PHD (plant homeodomain) zinc finger adjacent to a bromodomain at their C 
terminus47(Figure 2.1). The PHD zinc finger adjacent to the bromodomain has been 
shown to have a significant role in the NoRC function, binding to HDAC1 (histone 
deacetylase 1) DNMTs (DNA methyltransferases), and ATPase subunit SNF2h36. It has 
also been shown to belong to a PHD zinc finger family proteins that harbor 
PHD_nW_DD subtype7. Through next-generation sequencing efforts on diagnosed 
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patients’ genomes or cancer tissues, it has come to light that aberrations (mutations, 
overexpression) in proteins harboring PHD_nW_DD subtype are associated with 
different pathological consequences37, 48-53(Figure 4.1). For example, mutations in MLL2 
PHD has been reported to result in different types of cancers54-60. BAZ1A and MLL3 
have also been reported in rare tumors of gynaecological origin61.Therefore for future 
comprehension of the mechanisms for pathological consequences, as a first step, detailed 
characterization of the binding mechanism of the PHD_nW_DD was undertaken here, 
starting with one member (BAZ2A-PHD) of the subtype.  
          Systematic site-specific mutagenesis in the recombinant version of this BAZ2A-
PHD was performed, purified mutant proteins and measured interaction affinity between 
the mutant proteins and histone H3 using ITC (Isothermal Titration Calorimetry) to infer 
the molecular basis of the spatial connectivity or coupling between binding site amino 
acids and those away from the functional site.  
 
 
Figure 2.1. Domain organization of human BAZ2A containing PHD zinc finger adjacent to bromodomain: 
The MBD (methyl-CpG-binding domain) is the first domain, followed by the DDT (DNA binding 
homeobox and different transcription factors) domain, the PHD zinc finger is colored indigo which is 
adjacent to the bromodomain. 
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MATERIALS AND METHODS 
DNA constructs 
           The recombinant BAZ2A-PHD finger (residues 1673-1728 UniProt ID 
Q9UIF9/BAZ2A_HUMAN) used here was taken from an earlier work in the lab7. 
Briefly, BAZ2A-PHD was originally cloned into pETite N-His SUMO Kanamycin 
expression vector. 14 BAZ2A-PHD mutants (see mutant list in Table 2.8) were created 
using site directed mutagenesis. DNA sequences of wild type and all mutants were 
confirmed by DNA sequencing (Genscript). In total, 15 proteins (1 wild type and 14 
mutants) created in this study are used to probe the peptide binding mechanisms of PHD 
finger subtype (BAZ2A).  
 
Molecular Cloning 
           Synthetic DNA molecule of hBAZ2A-PHD of UniProt ID 
Q9UIF9/BAZ2A_HUMAN, residues 1673-1728 was obtained from GenScript and PCR 
(polymerase chain reaction) amplified using Thermo Scientific Phusion High Fidelity 
DNA Polymerase.  It was sub-cloned into pETite N-His SUMO Kanamycin expression 
vector (Lucigen). This was a ligation independent (enzyme-free) cloning and expression 
system in which the gene of interest was cloned under the control of the L-rhamnose-
inducible rhaPBAD promoter harbored on one of the pRhamTM vectors62, 63, which replaces 
the T7 promoter. The synthetic BAZ2A was PCR amplified with primers that contained 
short homology to the ends of the pETite N-His SUMO Kan vector (18 nucleotides of 
overlap with the ends of the vector)62-65. The PCR product was then mixed with the pre-
processed vector in a 1:1 ratio and transformed directly into the high-efficiency 
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chemically competent cells (E. cloni® 10G SOLOs Chemically Competent Cells, 
Lucigen). It was incubated overnight at 37°C for about 14 hours on kanamycin LB plate 
(see transformation). Colony PCR was done to confirm clones, and individual colonies 
were picked, cultured overnight at 37°C (for about 18 hours on kanamycin LB media). 
The recombinant DNA (pETite_BAZ2A) was isolated using QIAprep spin miniprep kit 
(QIAGEN). Agarose gel electrophoresis was run to confirm the presence and size of the 
miniprep sample before they were sent to GenScript for DNA sequencing. 
         After DNA sequence was verified, plasmid was transformed into HI-Control® BL21 
(DE3) SOLOs Chemically Competent cells (see transformation), protein expression was 
done and purified for the biophysical measurements with the ITC. Fourteen mutations 
were made in pETite_BAZ2A to change the amino acid residue positions to Alanine with 
Site-Directed Mutagenesis.  They were then expressed and purified for ITC 
measurements. 
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Figure 2.2.  The cloning design strategy of pETite_BAZ2A-PHD using the enzyme-free technology by 
Lucigen Simplifying genomics, where both forward and reverse primers are designed with 18 nucleotide 
sequences overlapping that of the pETite N-His SUMO Kan vector. 
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Table 2.1. The nucleotide and translated protein sequence of hBAZ2A for the cloning. The red colored 
portion of the primer sequence represents the short homology to the ends of the pETite N-His SUMO Kan 
vector (18 nucleotides of overlap with the ends of the vector). 
 Nucleotide Sequence 
hBAZ2A-PHD  
 
TCTGTCAACAAAGTGACATGTCTAGTCTGCCGGAAG
GGTGACAATGATGAGTTTCTTCTGCTTTGTGATGGG
TGTGACCGTGGCTGCCACATTTACTGCCATCGTCCC
AAGATGGAGGCTGTCCCAGAAGGAGATTGGTTCTG
TACTGTCTGTTTGGCTCAGCAGGTG 
 Protein Sequence 
 S V N K V T C L V C R K G D N D E F L L L C D G C D R 
G C H I Y C H R P K M E A V P E G D W F C T V C L A 
Q Q V  
Primers Primer Sequence 
Forward Primer (5’ to 
3’) 
CATCATCACCACCATCACTCTGTCAACAAAGTGACA
TGT 
Reverse Primer (5’to 3’) GTGGCGGCCGCTCTATTACACCTGCTGAGCCAAACA
GAC 
 
 
 
Table 2.2. Reagents for PCR: The reaction was set up on ice and the reagents were added in the order they 
appear in the table. 
Component Volume in 50µL Reaction/µL 
Distilled water 35.5  
5X Phusion buffer 10  
10mM dNTPs 1  
Forward Primer 1  
Reverse Primer 1  
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Template DNA 1  
Phusion DNA Polymerase 0.5  
 
 
Table 2.3. PCR reaction cycle: The entire reaction took about 2 hours 
Cycle step Temperature Time Cycles 
Initial Denaturation 98 °C 30sec 1 
Denaturation 
Annealing 
Extension 
98 °C 
62 °C 
72 °C 
10sec 
30sec 
1min30sec 
 
30 
Final Extension 
Final Hold 
72 °C 
4 °C 
10min 
∞ 
1 
 
 
Transformation 
           These steps were applicable to E. coli DH5α, BL21 cells or any other E. coli cells 
used for the cloning. The materials needed were 42 °C water bath, Ice, LB Plates with 
appropriate antibiotics (kanamycin for hBAZ2A-PHD), Sterile SOC or LB (no 
antibiotics) 
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Procedure 
• DH5α or BL21 competent cells from -80 °C freezer was put on ice for 30min. The 
competent cells were usually in eppendorf tube  
• Cells were gently mixed with the pipet tip (was not pipet up and down) and 30µL 
was aliquot into 1.5ml eppendorf tube that had been pre-chilled on ice. 
• 1µL of DNA was added to the cells and mixed gently 
• The tube was then incubated on ice for 30 minutes. 
• The SOC was Pre-warmed at 42°C 
• The cells were heat shocked for 45 seconds in a 42°C water bath without shaking. 
• The tube was then placed on ice for 2 minutes. 
• 250µL of SOC was added to the cells and incubated at 37°C for 1 hour at 225rpm. 
• The Kanamycin agar plate was pre-warmed in the incubator at 37°C. 
• 100µL of cells was inoculated and incubated at 37°C for overnight (12-16hours). 
 
Protein Expression and Solubility Test 
          The recombinant hBAZ2A-PHD was transformed into HI-Control® BL21 (DE3) 
SOLOs Chemically Competent cells (Lucigen) after the sequence was verified from 
GenScript. Three separate colonies on the Kanamycin agar plate were selected for a 
small-scale protein expression and solubility testing. This was done by inoculating them 
in a 4ml LB/kanamycin media and incubated at 225rpm, 37°C till the optical density at 
600nm (OD600) of each of the culture was between 0.2-0.4 (This was usually reached in 
4hours). Half of the volume of each culture (2ml) was transferred into a new eppendorf 
tube and induced with 1mM isopropyl β-D-1-thiogalactopyranoside (IPTG). They were 
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then allowed to grow for another 3hours at the same conditions as above. The rest of the 
test was carried out by the procedure below: 
• The cell cultures were pelleted in pre-weighed eppendorf tubes by centrifuging at 
13000rpm for 10mins 
• 0.5g of the pelleted cells were completely resuspended in a 1ml solution of 1x bug 
buster. 
• The suspension was incubated on a shaker at 4°C for 20mins and then centrifuged 
at 13000rpm for 10mins. 
• The supernatant, which now contains the soluble protein, was separated from the 
pellet and SDS-PAGE gel run to determine the solubility of the protein 
• The remaining pellet (both induced and uninduced) was also used to run SDS- 
PAGE gel to determine the expression of each colony picked. 
	
A	
	
	
	
	
	
	
	
	
	
	
	
	
	 	
 
 
	
	
	
 
	
	
	
	
19		
B 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3. (A) SDS-PAGE gel of hBAZ2A-PHD Solubility test showing that the protein is soluble hence 
can be seen in the supernatant with the size of 18.4KDa. Lane 2, which is the pellet, does not show such a 
band, which means the protein, is clearly not in the pellet hence it is a soluble protein. 
(B) SDS-PAGE gel of the expression test of 3 colonies of hBAZ2A-PHD. Lanes 1, 3 and 5 represents the 
uninduced colonies. Lanes 2, 3 and 6 represents the colonies induced with 1mM IPTG. It can clearly be 
seen that the induced colonies have bands at the 18.4KDa mark whereas the uninduced do not have that 
band in the gel. Lane 7 represents the protein ladder that was used to determine the size of the protein.  
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Protein Expression and Purification 
          After it was determined that the recombinant protein was soluble and could be 
expressed, a 4litre culture was prepared by growing 30ml culture in an LB/kanamycin 
media overnight at 37°C, 225rpm. The overnight grown culture was transferred to an 
autoclaved terrific broth/kanamycin media and allowed to grow in a 37°C incubator at the 
same rotation speed as above till the OD600 was between 0.6 and 1. The culture was then 
induced with 1mM IPTG and transferred to a 16°C shaker (N-Biotek) at rotating speed of 
225rpm and allowed to grow overnight (approximately 18hrs). The protein was isolated 
and purified by His-tag affinity chromatography.  
          The overexpressed cells were lysed in a phosphate buffer (25mM phosphate buffer, 
300mM NaCl at pH 7.6) with 10mg/ml of lysozyme, which facilitates in breaking the cell 
wall of the bacteria to release the soluble protein in the buffer and 0.1mg/ml of IGEPAL-
CA 600 (a nonionic, non-denaturing detergent which prevents surface-induced protein 
aggregation in the buffer). The number of bacteria cells in the resuspension phosphate 
buffer should be 30%. The resuspension was allowed to stand on ice for 30minutes 
before it was treated with a Misonix ultrasonic liquid processor (Sonicator S-4000) for 5 
minutes that further lysed the cells. The lysates were cleared by centrifugation (18000rpm 
for 30min at 4°C, Beckman J2-MI centrifuge). After centrifugation, the supernatant that 
contained the soluble protein was loaded on a phosphate buffer equilibrated nickel 
sepharose high performance bead (GE Healthcare Life Sciences) overnight. The protein 
was then eluted with an imidazole (200-250mM) solution at pH 7.6. It was finally 
polished or purified to homogeneity by size exclusion gel filtration chromatography using 
a HiLoad 26/600 superdex column using AKTA prime FPLC (GE Healthcare Life 
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Sciences). The phosphate buffer at this step had 150mM NaCl.  The peak corresponding 
to the size of the protein was concentrated to the desired volume and concentration 
determined by UV-Vis Nanodrop Spectrophotometer and Bradford Method. The purity of 
the protein was confirmed by SDS-PAGE (Bio-Rad). 
          It must be stated that different conditions at the elution step (in terms of the amount 
of salt in the buffer, the concentration of imidazole needed for the elution of the protein) 
were tried in order to arrive at the optimized condition used for the purification (Figure 
2.3 and 2.4).  
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Figure 2.4.  FPLC profile with different NaCl salt concentrations in 25mM phosphate buffer to determine the optimum salt concentration needed for the elution 
of BAZ2A-PHD. The Y-axis is the absorbance in mAu and the X-axis is the volume in ml. The various concentrations of the salt were used at the elution step 
before loading the protein into the AKTA prime FPLC 
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Figure 2.5. FPLC profile with different imidazole concentrations in 25mM phosphate buffer to determine the range of imidazole concentration required for the 
elution of BAZ2A-PHD. The Y-axis is the absorbance in mAu and the X-axis is the volume in ml. The various concentrations of the imidazole were used at the 
elution step before loading the protein into the AKTA prime FPLC
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Figure 2.6. (A) SDS-PAGE gel of hBAZ2A-PHD purification process. The concentrated peak was 
reloaded on the AKTA prime to get a much more purer protein as seen at B (B) FPLC profile of purified 
hBAZ2A-PHD in 25mM phosphate buffer, 150mM NaCl, pH of 7.6, and the SDS-PAGE gel representing 
the peak. 
 
Determination of Protein Concentration by Bradford Method 
Table 2.4. Absorbance measurements and concentration of Bovine Serum Albumin (BSA) used for the 
Bradford standard curve 
Tubes	 Absorbance 1 
Absorbance 
2 
Absorbance 
3 
Average 
Absorbance 
at 595nm 
Concentration 
(mg/ml) 
1 1.347 1.373 1.37 1.36 2 
2 1.278 1.254 1.251 1.26 1.5 
3 1.118 1.117 1.112 1.12 1 
4 0.953 0.938 0.948 0.95 0.75 
5 0.8 0.792 0.791 0.79 0.5 
6 0.616 0.602 0.606 0.61 0.25 
7 0.509 0.494 0.476 0.49 0.125 
8 0.366 0.386 0.362 0.37 0 
 
Figure 2.7.  Standard curve used for the determination of the protein concentration. It was performed from 
the Quick Start Bradford Protein Assay protocol where 250µL of the Bradford solution and 5µL of each of 
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the dilutions made from the standard BSA were used for the absorbance measurements. The equation of the 
curve was used for the estimation of the protein concentration. 
 
Mutagenesis 
          Fourteen mutants were made from the hBAZ2A-PHD to change the amino acid 
residue positions to Alanine with Site-Directed Mutagenesis.  hBAZ2A-PHD residues 
that undergo a change in the accessible surface area with the peptide, ΔASASC, ≥ 10Å2 of 
the side chain atoms were considered. Distal amino acid residues as well as aspartates in 
the PHD treble-clef knuckle were also considered for the mutagenesis. Another factor 
that was also taken into consideration in selecting which amino acid residue to mutate 
was the distal negatively charged amino acid residues since histone H3 peptide is 
positively charged hence it was expected that, electrostatics could contribute to the 
binding. 
          Primers were designed and ordered from Integrated DNA Technologies (IDT) and 
Site Directed Mutagenesis performed (Table 2.5 and Table 2.7). Most of the mutants 
were obtained by using gradient PCR, where varying annealing temperatures were 
employed to get the mutations to work. 
 
Table 2.5. Mutagenesis reaction cycle: The entire reaction took about 1hour 45minutes 
Cycle step Temperature Time Cycles 
Initial Denaturation 98 °C 30sec 1 
Denaturation 
Annealing 
98 °C 
Varying 
10sec 
30sec 
 
18 
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Extension 72 °C 1min30sec 
Final Extension 
Final Hold 
72 °C 
4 °C 
10min 
∞ 
1 
 
 
Table 2.6. Reagents for Mutagenesis: The reaction was set up on ice and the reagents were added in the 
order they appear in the table. 
Component Volume in 50µL Reaction/µL 
Distilled water 35.5  
5X Phusion buffer 10  
10mM dNTPs 1  
Forward Primer 1  
Reverse Primer 1  
Template DNA 
(pETite_BAZ2A-PHD) 
1  
Phusion DNA Polymerase 0.5  
 
Table 2.7. Primers used for the Site Directed Mutagenesis of hBAZ2A-PHD. The letter colored red is the 
site of mutation 
Mutant Forward Primer (5’-
3’) 
Reverse Primer (5’-3’) Protein Sequence 
V1674A CAGATTGGAGGT 
TCTGCCAACAAA 
GTGACCTGC 
GCAGGTCACTT 
TGTTGGCAGAA 
CCTCCAATCTG 
AHREQIGGSANK 
VTCLVCRKGDND 
EFLLLCDGCDRGC 
HIYCHRPKMEAVPE 
GDWFCTVCLAQQV 
	
	
	
28	
D1688A CGGAAGGGTGAC 
AATGCTGAGTTT 
CTTCTGCTT 
AAGCAGAAGAA 
ACTCAGCATTGT 
CACCCTTCCG 
SVNKVTCLVCRKG 
DNAEFLLLCDGCDR 
GCHIYCHRPKMEAV 
PEGDWFCTVCLAQQV 
E1689A AAGGGTGACA 
ATGATGCGTTT 
CTTCTGCTTTGT 
ACAAAGCAGAA 
GAAACGCATCA 
TTGTCACCCTT 
SVNKVTCLVCRKG 
DNDAFLLLCDGCDR 
GCHIYCHRPKMEAV 
PEGDWFCTVCLAQQV 
L1692A ACAATGATGAG 
TTTCTTGCGCTTT 
GTGATGGGTGTGA 
TCACACCCATCA 
CAAAGCGCAAGA 
AACTCATCATTGT 
SVNKVTCLVCRKG 
DNDEFLALCDGCDR 
GCHIYCHRPKMEAV 
PEGDWFCTVCLAQQV 
L1693A ATGATGAGTTTC 
TTCTGGCTTGTGA 
TGGGTGTGACCG 
CGGTCACACCCA 
TCACAAGCCAGA 
AGAAACTCATCAT 
SVNKVTCLVCRKG 
DNDEFLLACDGCDR 
GCHIYCHRPKMEAV 
PEGDWFCTVCLAQQV 
D1695A TTTCTTCTGCTT 
TGTGCTGGGTGT 
GACCGTGGC 
GCCACGGTCACA 
CCCAGCACAAAG 
CAGAAGAAA 
SVNKVTCLVCRKG 
DNDEFLLLCAGCDR 
GCHIYCHRPKMEAV 
PEGDWFCTVCLAQQV 
D1698A CTTTGTGATGGG 
TGTGCCCGTGGC 
TGCCACATT 
AATGTGGCAGCC 
ACGGGCACACCC 
ATCACAAAG 
SVNKVTCLVCRKG 
DNDEFLLLCDGCAR 
GCHIYCHRPKMEAV 
PEGDWFCTVCLAQQV 
V1713A CCCAAGATGGA 
GGCTGCCCCAGA 
AGGAGATTGG 
CCAATCTCCTT 
CTGGGGCAGCC 
TCCATCTTGGG 
SVNKVTCLVCRKG 
DNDEFLLLCDGCDR 
GCHIYCHRPKMEAA 
PEGDWFCTVCLAQQV 
E1711A CATCGTCCCAA 
GATGGCGGCTG 
TCCCAGAAGGA 
TCCTTCTGGGA 
CAGCCGCCATCT 
TGGGACGATG 
SVNKVTCLVCRKG 
DNDEFLLLCDGCDR 
GCHIYCHRPKMAAV 
PEGDWFCTVCLAQQV 
E1715A ATGGAGGCTGTC 
CCAGCAGGAGAT 
TGGTTCTGT 
ACAGAACCAAT 
CTCCTGCTGGGA 
CAGCCTCCAT 
SVNKVTCLVCRKG 
DNDEFLLLCDGCDR 
GCHIYCHRPKMEAV 
PAGDWFCTVCLAQQV 
V1728A GTCTGTTTGGCTC 
AGCAGGCGTAAT 
AGAGCGGCCGCCAC 
GTGGCGGCCGCTC 
TATTACGCCTGCT 
GAGCCAAACAGAC 
SVNKVTCLVCRKG 
DNDEFLLLCDGCDR 
GCHIYCHRPKMEAV 
PEGDWFCTVCLAQQA 
SSSGRHR 
D1686A GTCTGCCGGAAG 
GGTGCCAATGAT 
GAGTTTCTT 
AAGAAACTCATC 
ATTGGCACCCTTC 
CGGCAGAC 
SVNKVTCLVCRKG 
ANDEFLLLCDGCDR 
GCHIYCHRPKMEAV 
PEGDWFCTVCLAQQV 
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D1717A GCTGTCCCAGAAG 
GAGCTTGGTTCTG 
TACTGTC 
GACAGTACAGAA 
CCAAGCTCCTTC 
TGGGACAGC 
SVNKVTCLVCRKG 
DNDEFLLLCDGCDR 
GCHIYCHRPKMEAV 
PEGAWFCTVCLAQQV 
N1675A AGATTGGAGGTTC 
TGTCGCCAAAGTG 
ACCTGCCTGGT 
ACCAGGCAGGTCA 
CTTTGGCGACAGAA 
CCTCCAATCT 
HREQIGGSVNKVTCLV 
CRKGDNDEFLLLCDGC 
DRGCHIYCHRPKMEAV 
PEGAWFCTVCLAQQV 
 
           
          After the mutagenesis reaction, Dpn I digestion was done at 37°C for 2hours to 
destroy the template (hBAZ2A-PHD wild type DNA). Enzyme inactivation of the Dpn I 
was done at 80°C for 20mins to inactivate the enzyme after digesting the parental 
supercoil dsDNA. The mutants were transformed into XL 10-gold competent cells and 
then incubated on a kanamycin agar plate at 37°C for 14hours. Colonies obtained on the 
kanamycin agar plates were cultured and allowed to grow at 37°C for 18hours in a 
kanamycin/LB media and then miniprep performed according to the QIAprep spin 
miniprep kit protocol (QIAGEN). 1% DNA agarose gel was prepared in 1x TAE buffer; 
pH 8.0 and the samples run to determine the presence of the mutants (Figure 2.8). The 
samples were then packaged and sent for sequencing (Genscript) to determine the right 
nucleotide sequence of each of the mutants. 
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Transformation, Expression and Purification of Mutants 
          After confirming the DNA sequences of all the mutants, they were transformed 
into HI-Control® BL21 (DE3) SOLOs Chemically Competent cells (see transformation). 
Solubility test and small-scale expression was done to select the best colonies for all the 
mutants. 4-liter culture was prepared for each mutant and purified as described above for 
the purification of the wild type.  
 
Figure 2.9. SDS-PAGE gel showing the expression of some of the mutants of hBAZ2A-PHD: For each of 
them, an induced and an uninduced sample was run to clearly show that proteins are being expressed. The 
protein was run with a 12% SDS-PAGE gel in a 1x running buffer with a 120 voltage for 60 minutes. 
					
	
	
	
	
Figure 2.8.  Agarose gel electrophoresis of hBAZ2A mutants before DNA samples were sent for 
DNA sequencing. Lane 1 (hBAZ2A wild type) was run as marker to confirm the size and 
behavior of the plasmid in the agarose gel.  
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Figure 2.10 (A-D).  Chromatograms showing the FPLC profile peaks of purified V1674A, D1688A, 
E1689A and L1692A respectively. They were all run at 4°C in 25mM phosphate buffer (150mM NaCl salt, 
pH of 7.6). The tubes corresponding to these peaks were concentrated using an ultra-filtration tube with a 
10kDa molecular weight cut off. 
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Figure 2.10 (E-H).  Chromatograms showing the FPLC profile peaks of purified L1693A, D1695A, 
D1698A and V1713A respectively. 
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Figure 2.10 (I-K).  Chromatograms showing the FPLC profile peaks of purified E1711A, E1715A, and 
V1728A respectively. All the proteins were eluted with 100ml of 150mM imidazole in 1x phosphate buffer 
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and concentrated to 4ml before loading into the AKTA prime FPLC at 4°C. The column used was the 
HiLoad 26/600 superdex column. The tubes corresponding to the peaks were concentrated to 0.1mM for 
the ITC measurement. 
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Figure 2.10 (L-N).  Chromatograms showing the FPLC profile peaks of purified D1686A, D1717A, and 
N1675A respectively.  
 
 
Synthetic Peptides 
          98% pure Histone H3 synthetic peptide with residues 1-11 (H3-1-11W) was 
ordered from Genscript for the binding studies of the wild type and the mutants of 
hBAZ2A-PHD proteins. The W in the synthetic peptide sequence represents C-terminal 
Tryptophan residue. H3-1-11W. The C-terminal Tryptophan residue in the peptide was 
used for estimating peptide concentrations by absorbance using the computed molar 
extinction coefficient66, which is 5.5M-1cm-1. The purity of the Histone H3-1-11W 
peptide was confirmed with mass-spectroscopy. 
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Synthetic Peptide and Recombinant Protein Concentration Measurements  
           The wild type and mutant proteins of hBAZ2A-PHD from the FPLC HiLoad 
26/600 superdex column were concentrated using the Amicon Ultra-15 Centrifugal Filter 
Units (Millipore) with a 10kDa molecular weight filter since the size of the recombinant 
proteins was 18.4kDa. The concentration was determined by using the UV-Vis Nanodrop 
Spectrophotometer to measure the absorbance of the proteins at 280nm (which is the 
absorption wavelength for tryptophan) and then the concentration calculated by using the 
molar extinction coefficient obtained from ExPaSy ProtParam tool (a bioinformatics 
software for computing the chemical and physical properties of proteins). The molar 
extinction coefficients of the hBAZ2A-PHD proteins and Histone H3 1-11W peptide are 
8.48 M-1cm-1 and 5.5 M-1cm-1 respectively. 
The concentrations were confirmed by using the Bradford Protein Assay standard curve 
(Figure 2.7) that was generated by the using Quick Start Bradford Protein Assay protocol. 
 
Isothermal Titration Calorimetry (ITC) 
          The peptides and recombinant proteins (wild type hBAZ2A and mutants) for ITC 
were both prepared in the same buffer (25 mM phosphate, 150 mM sodium chloride at 
pH=7.6). The thermodynamics of binding between a protein and the synthetic peptides 
were studied using MicroCal ITC200 (GE Healthcare) with protein (0.1-0.15 mM) and 
peptide (10 fold higher) respectively loaded in the cell and syringe at 25°C. Twenty 2µl-
injections with a 3-minute injection-interval, with a syringe stirring speed of 1000 rpm 
were used for the titrations. DG° of peptide binding at 25°C was computed as –RTln (Ka) 
where R, T and Ka are respectively the gas constant, temperature and association 
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constant. DDG° for a residue’s energetic contribution is estimated as DDG° = DG°mutant - 
DG°wildtype. All titrations were carried out in identical conditions of buffer and 
temperature. In the case of many of the mutants, no binding was observed (i.e. negligible 
amount of observed heats) and data fitting was unreliable to the observed enthalpy. In 
such cases it was assumed that DDG° (>> 1.5 kcal.mol-1) was large. Tryptophan residue 
of the PHD finger was used for estimating protein concentrations by absorbance using the 
computed molar extinction coefficient66. Titrations were also performed at 250 mM 
sodium chloride buffer (25 mM phosphate at pH=7.6) to check the influences of 
electrostatics on the protein-peptide interactions. Binding measurements (titrations) for 
each protein was run in triplicate to confirm the data. 
 
 
RESULTS AND DISCUSSIONS 
Contribution of electrostatics on peptide binding 
          Histone H3 peptide is positively charged, and there is a considerable distribution of 
negatively charged residues around the binding surface of BAZ2A-PHD finger (Figure 
2.11A). It is likely that electrostatics would influence peptide-binding interactions. For a 
qualitative estimate of the influence of electrostatics, we carried out experiments at both 
150mM NaCl salt and 250mM NaCl salt for the wild type protein. It was observed that, 
by increasing the salt concentration by 100mM, the free energy (ΔG) of peptide binding 
at 25°C becomes unfavorable by ~0.7kcal/mol (or 3.35 fold affinity drop) confirming the 
role of electrostatics in the overall binding interactions (Figure 2.11A, 2.12). This 
suggests that the binding is driven by electrostatics hence higher salt concentration 
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shields the electrostatics. Thus, in selecting the control residues, among several other 
possible residues, distal negatively charged residues (E1711 and E1715) were preferred. 
The peptide in complex with BAZ2A-PHD possesses three positive charged centers, 
which are normally involved in the electrostatic interaction. These centers are: (i) the N-
terminal NH3+ -group, (ii) the CZ- atom of Arginine-2 and (iii) the NZ- atom of Lysine-4. 
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Figure 2.11. (A) Electrostatic potential (isocontour value of ± 76.3 kT/e) surface representation of the 
BAZ2A PHD bound to the H3-1-5 residue peptide (splitpea), (B) Side-chain atoms of BAZ2A-PHD 
residues that are mutated to Alanine in this study are represented in sticks (light-pink). Positions of interest 
are labeled as L1, L2, D1, and D2. (C) Side-chains of positions of control mutations are also represented in 
sticks.  
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Figure 2.12. ITC binding studies between histone H3 unmodified N-terminal peptide and wild type of 
BAZ2A-PHD at (A) 150mM NaCl Salt and (B) 250mM NaCl salt. (C) Overlayed titration profiles of the 
wild types at different salt concentrations. The Kd is reduced by 3.35 fold by changing the salt from 
250mM to 150mM. 
 
Dissecting the energetic contributions of BAZ2A-PHD residues 
          The recently reported 1.9-Å X-ray structure of BAZ2A-PHD47(pdb code 4q6f) in 
complex with the unmodified histone H3 N-terminal peptide (Figure 2.11A) is used here 
as the starting point for inferring the energetic contributions of BAZ2A-PHD residues 
towards peptide binding. BAZ2A-PHD residues that undergo a change in the accessible 
surface area, ∆ASA, ≥ 10Å2 of the side chain atoms are considered for probing the 
energetic contributions (Figure 2.11B, see Methods) by mutagenesis. Seven BAZ2A-
PHD residues lose ~15Å2 or more of their side-chain surface area upon complex 
formation, and we consider these residues as the primary contacts for histone H3 peptide 
(Figure 2.11B). However, D1698 (∆ASA = 0) is also included in the list of residues for 
mutagenesis (Figure 2.11B). This is because, in an earlier study7, it had been noted that 
C	
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D1698 of BAZ2A is the second of the pair of Asp residues in the PHD treble-clef 
knuckle xCDxCDx sequence pattern, a feature present in a distinct PHD subgroup that 
includes the double PHD finger (DPF or also referred as the tandem-PHD-PHD) type of 
modules (Figure 3.1). To probe the binding energetics by mutagenesis, we also included 
three control residues (E1711, E1715 and V1728) that are either distal from the peptide-
binding site (∆ASA @ 0) (Figure 2.11A, C). The selected eleven positions were 
substituted to Alanine, and mutants were then purified for probing histone H3 peptide 
binding energetics by isothermal titration calorimetry (ITC) (Figure 2.13-2.14 and Table 
2.8). For comparison of the wild type protein’s peptide-binding behavior with that of the 
rest of the mutants, ∆G and Kd at 25°C are summarized in table 2.8. We then probed the 
eleven mutants to learn if factors in addition to electrostatics would contribute to the 
overall binding energetics.  
          Mutations at three positions (L1692A, L1693A and D1695A) completely aborted 
peptide binding, i.e. titrations with these mutants did not show any detectable enthalpy 
change (Figure 2.13, 2.14(D-F) and Table 2.8). Based on the binding enthalpy, for the 
rest of the mutants, we observed a range of binding behaviors (Figure 2.13-2.14, Table 
2.8). However, none of them completely disrupted peptide binding. Thus, we anticipate 
that L1692A, L1693A and D1695A make very large energetic contributions towards 
peptide binding, and these residues likely dominate the peptide binding energetics. It is 
interesting to note two nonpolar residues (L1692 and L1693) are among the residues 
dominating the binding energetics between the two oppositely charged interacting 
partners. We discuss the details of the binding energetic observations of BAZ2A-PHD 
finger in the context of the PHD superfamily in the next chapter. 
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Table 2.8. (A) A listing of the structural (DASA) and thermodynamic (Ka, Kd, DGo) properties of the 
mutated BAZ2A-PHD positions listed in the study	
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Table 2.8. (B) A listing of the structural (DASA) and thermodynamic (Ka, Kd, DGo) properties of the 
mutated BAZ2A-PHD positions that are remote from the peptide binding site (distal site) but disrupts 
peptide binding.	
Mutant ΔASASC (Å2)      Ka (M-1) Kd (µM) ΔG°(Kcal/mol) 
D1686A        0.00            X          X          X 
D1717A        0.95            X          X           X 
N1675A       20.23            X          X           X 
 
	
																																																													
Figure 2.13 (A) ITC binding studies between histone H3 unmodified N-terminal peptide, and wild type, 
mutants of BAZ2A-PHD. A representative isothermal calorimetric titration (top) of H3-1-9 peptide 
(syringe) into protein (cell) is shown for the wild type protein while exothermic heats (bottom) exchanged 
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per mol of injectant as a function of the molar ratio of peptide to protein is overlayed for all titrations for 
convenience. (B) DGo of the forward binding reaction for the wild type and mutants are shown as bar. For 
convenience -DGo is shown. Residues that contribute more than 1 kcal/mole of free energy are below the 
black dotted line. Red bars for positions where binding was not detected in ITC experiments.	
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Figure 2.14.(A-H) ITC binding studies between histone H3 unmodified N-terminal peptide and mutants of 
BAZ2A-PHD. A representative isothermal calorimetric titration (top) of H3-1-9 peptide (syringe) into 
protein (cell) is shown for the mutant proteins while exothermic heats (bottom) exchanged per mol of 
injectant as a function of the molar ratio of peptide to mutant proteins. From A to H are V1674A, D1688A, 
E1689A, L1692A, L1693A, D1695A, D1698A and V1713A respectively. 
 
Contributions of negatively charged residues at BAZ2A interface 
          Since BAZ2A belongs to a subtype that is characterized by the presence of a pair 
of negatively charged residues at the treble clef knuckle, we first wanted to understand 
the contributions of the BAZ2A D1695 (D1 position) and D1698 (D2 position) residues 
as a first step so we can better understand in the context of subtype structure in the next 
chapter. The substitution of D1695 severely compromised binding. Side-chain 
carboxylate at D1 is engaged in a salt bridge mediated interaction with the H3Arg2 
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residue. The complete loss of binding upon D1695 substitution was expected due to the 
loss of the electrostatic interaction between D1695 and H3Arg2, and thus D1695 has a 
very large energetic contribution. DDG for BAZ2A D1698 (D2 position) was however, 
0.67 kcal/mole (Figure 2.13, 2.14F-G and Table 2.8). The contribution of D1698 (D2 
position, 0.67 kcal/mole) could be less than that of the D2 position of other members 
because of a structural deviation of the treble clef xCDxCDx knuckle in BAZ2A PHD 
noted in Figure 2.15. In comparison with what is typically observed in other PHD fingers, 
the structural deviation of the knuckle places BAZ2A D1698 farther away from the 
H3Arg2 residue. This structural deviation is also reflected in the loss of the surface area 
upon complex formation. 
 
Figure 2.15. BAZ2A-PHD treble clef knuckle Asp pair:  Structural deviation and distances between 
oppositely charged atoms among the PHD_nW_DD subtype structures anchoring histone H3-Arginine 2 
residue. 
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          BAZ2A D1698, with 0.0Å2 DASAsc, having a non-zero energetic contribution 
towards peptide binding also suggested that other negatively charged residue control 
mutations (Figure 2.11C) might have non-zero energetic contributions possibly through 
long-range electrostatics. The DDG for BAZ2A E1711A and E1715A control mutations 
are respectively 0.09 and 0.94 kcal/mol (Figure 2.17-2.18, Table 2.8). The peptide in 
complex with BAZ2A-PHD possesses three positive charge centers: (i) the N–terminal 
NH3+–group, (ii) the CZ–atom of Arg2 and (iii) the NZ–atom of Lys4. For the E1715 
residue, closest of these three peptide positive charge centers is the N–terminal NH3+–
group at 6.4Å away (Figure 2.17A). For comparison, the closest positive charge center 
for the D1 residue carboxylate oxygen atoms is the H3R2-CZ atom at 3.46 ± 0.04Å in 
BAZ2A where we note large energetic contribution from the D1 position. Noting the 
distances of these distal site positions (E1711 and E1715) in BAZ2A, it is unlikely that 
the energetic contributions of these sites can be explained merely by electrostatics. 
Recent reports on distal site perturbations modulating binding in small sized domains 
suggest that67, 68, in addition to electrostatics, other structural effects such as the influence 
on protein dynamics and/or change in the structure could be associated with contributions 
of these distal sites. Influence of distal site perturbations on binding is not uncommon for 
PHD fingers, e.g. binding of BCL9 peptide at a distal site on Pygo-PHD (Figure 2.17B) 
enhances the PHD canonical site’s affinity for histone H3 by 2-3 fold69. Probing distal 
site perturbations of mutations will however require further study. The next chapter will 
try to determine if these positions show a subtype specific enrichment for the distal 
negatively charged residue.  
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Figure 2.16A.  Negatively charged residue control mutants. ITC binding studies between histone H3 
unmodified N-terminal peptide and mutants of BAZ2A-PHD. A representative isothermal calorimetric 
titration (top) of H3-1-9 peptide (syringe) into protein (cell) is shown for the mutant proteins while 
exothermic heats (bottom) exchanged per mol of injectant as a function of the molar ratio of peptide to 
mutant proteins. (A) on left is E1711A, and (B) on right is E1715A, (C) below V1728A. 
 
Figure 2.16B.  Overlayed titration profiles of the control mutants: ITC binding studies between histone H3 
unmodified N-terminal peptide and mutants of BAZ2A-PHD  
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A 
 
Figure 2.17A. Distances of positive charge centers from the site of mutation (left), and for comparison, 
distances for D1 position (right). 
 
B     
 
Figure 2.17B. Structural example of the distal site perturbation of Pygo-PHD by BCL9 peptide. 
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Figure 2.18. The fitted values of ΔH and ΔG obtained using ITC experiments are graphically represented 
for each BAZ2A mutation. The number next to the error bar represents the error (in percentage) associated 
with the fitted enthalpy. 
 
Distal Mutations that Disrupts Histone H3 Peptide binding 
          We looked at 3 other positions D1686, D1717 and N1675 (Figure 2.19) on the 
hBAZ2A-PHD surface, which were at a distal site from the histone H3 binding site. Our 
observation from the energetics was however quite interesting. All these 3 positions had 
significant contribution towards the protein-peptide complex formation since their 
mutations caused the interaction to be aborted. It is however not clear whether the 
influence is due to a long range electrostatic70, 71 hence a mutation leads to the significant 
drop in the energetics. The observation could also be as a result of a dynamic motion of 
these positions hence their mutations causes the interruption of their coupling effect on 
the protein-peptide complex formation68, 72-79. All the possible scenarios could be 
confirmed by doing a structural study analysis, which will be conducted as the next phase 
of the work.  
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Figure 2.19. Distal site residue mutants: ITC binding studies between histone H3 unmodified N-terminal 
peptide and mutants of BAZ2A-PHD. A representative isothermal calorimetric titration (top) of H3-1-9 
peptide (syringe) into protein (cell) is shown for the mutant proteins while exothermic heats (bottom) 
exchanged per mol of injectant as a function of the molar ratio of peptide to mutant proteins. (A) D1686A 
(B) D1717A (C) N1675A- The Stoichiometry (N) could not be fitted for this mutant hence the data fitting 
is unreliable to the observed enthalpy. As a result, DDG° (>> 1.5 kcal.mol-1) is large or the observed 
amount of heat is considered to be negligible. 
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CHAPTER III 
BAZ2A AND PHD ZINC FINGER SUBTYPE 
ABSTRACT 
       Although the plant homeodomain (PHD), a binuclear interleaved Zn-chelating 
domain finger superfamily is well known for its site-specific readouts of histone tails, 
mechanistic details of the readouts remain poorly understood. Starting with BAZ2A-
PHD (one member of the PHD_nW_DD subtype), key histone peptide anchoring residue 
positions were first identified by site-specific mutagenesis. Loss of interfacial packing, 
due residue substitution, contributes to the observed binding energetics. The peptide 
anchoring residue positions (ΔΔG≥ 1.0kcal/mol) of BAZ2A-PHD, interestingly, are 
enriched in specific type of residues in a subtype specific manner. The energetic 
contribution of the identified positions were further confirmed by mutagenesis in other 
three members of the subtype (UHRF1-PHD, KDM5B-PHD, KAT6A-PHD) that 
included pairs sharing even less than 40% sequence identity with each other. Despite low 
sequence similarity, mutations cause similar consequences in histone H3 binding 
suggesting a strong similarity in the binding mechanism. 
         The experimental data suggests that the binding mechanism of the PHD_nW_DD 
likely originated early to anchor residue 1-3 of histone H3, featuring a characteristic 
treble clef knuckle Aspartate residues for anchoring the peptide Arginine hotspot while 
the acidic patch residues contribute to the helical conformation of N-terminal histone H3. 
A set of non-polar amino acids is among the residues enriched in the PHD_nW_DD 
subtype, and these non-polar amino acids tightly pack against the peptide residues with 
small side-chains, present on either side of the peptide hotspot Arginine residue. 
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INTRODUCTION 
          From chapter two, we experimentally discovered two categories of mutations that 
disrupt peptide binding: (1) Type-A: positions that are in contact with the peptide and (2) 
Type-B: positions that are remote from the peptide-binding site (distal site). For this 
chapter of the dissertation, we focused on understanding the biochemical basis of the 
effects of Type-A mutations using recombinant protein chemistry and biophysical 
chemistry. Moreover, having observed the energetics of the histone binding mechanism 
of histone H3 peptide and human BAZ2A-PHD, we wanted to ascertain if the features we 
observed were features that could be said to be true of the PHD_nW_DD subtype or they 
were features that were unique to BAZ2A-PHD.  
          To confirm this, three members of the PHD_nW_DD subtype were selected. One 
member, KDM5B-PHD7, 18, 80 had sequence identity of 60% but the other two, UHRF1-
PHD19 and KAT6A-PHD81 had sequence identity of less than 40% (Figure 3.1B and 3.2). 
Wild types of these proteins were cloned and purified for the biophysical measurements 
using ITC. Site-specific mutations were also performed on these selected members 
(Type-A mutations). For simplicity, the D1695, D1698, L1692, and L1693 positions in 
BAZ2A-PHD will be referred to as D1, D2, L1, and L2 respectively in corresponding 
positions in selected members of the subtype. 
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Figure 3.1. The chosen PHD fingers: (A) Cartoon representation of the domain organization of proteins 
bearing the distinct subfamily of PHD (blue). This PHD subtype occurs in combination with variety of 
other domains. (B) Double PHD Finger (DPF) are aligned with single PHD finger sequences to highlight 
the common feature of treble clef Aspartate residues. UniProt accession ids and residue boundaries are 
indicated left of the alignment. Non-redundant sequences (85% sequence identity) are used to generate the 
alignment using muscle. PHD1 and PHD2 of DPFs respectively are in gray and black, with KAT6A DPF 
(bottom, right) highlighting the location of treble clef Asp residues in DPF-PHD2. Among subtype, 10% 
are DPFs and 90% are isolated PHD. 
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Figure 3.2. PHD, zf-CW and the L1 position: (A) MUSTANG structural alignment of PHD finger. The 
protein names are on the left of the alignment, and pdb ids, residue boundary and resolution are on the right 
of the alignment. PHD fingers with < 40% sequence identity are chosen, and the ‘]’ symbol to the right of 
the alignment indicates some pairs with sequence slightly above 40% sequence identity. (B) MUSTANG 
structural alignment of zf-CW domains that have < 40% sequence identity with one another. The dotted 
lines between the zf-CW and PHD structural alignments indicate the segment containing the strand-
knuckle-strand. L1 and L2 positions in the alignment are respectively in green and red color. (C) The 
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structure of MORC3 zf-CW domain in complex with histone H3K4me3 peptide (left). The surface mesh 
represents contact between H3A1-CH3 and L1. The structure BPTF PHD finger (right) with a similar 
pattern of aromatic cage residues as that of zf-CW. (D) Similarity in the sequence logo between zf-CW and 
PHD_W subtype for the pair of strands that augments the peptide. 
           
MATERIALS AND METHODS 
DNA constructs and Mutagenesis of Subtype proteins  
          The wild type proteins selected for this section of the work had already being 
cloned and sequences verified from GenScript by Dr. Chakravarty’s lab7. Briefly, 
recombinant His-tag fusion of hUHRF1 PHD (residues 299-367 UniProt ID 
Q96T88/UHRF1_HUMAN) and hKAT6A DPF (residues 196-319 UniProt ID 
Q92794/KAT6A_HUMAN) were cloned into a modified pET28A vector using BamHI 
and XhoI restriction sites. The pET28A modification is that the Thrombin protease 
cleavage site DNA sequence was modified to incorporate BamHI restriction site without 
altering the protein sequence. PCR (polymerase chain reaction) amplification of synthetic 
DNA representing the sequences of hUHRF1 PHD and hKAT6A DPF were first carried 
out for creating the desired constructs. Synthetic DNA molecules were obtained from 
GeneScript. Mutants of hUHRF1 PHD (L344A, M345A, and D350A) and hKAT6A DPF 
(L279A, F280A, and D285A) were created by site directed mutagenesis (refer to chapter 
2 for procedure and conditions). The recombinant GST fusion hKDM5B PHD (residues 
305-366 of UniProt ID Q9UGL1/KDM5B_Human) and hAIRE PHD (residues of 294-
343 UniProt ID O43918/AIRE_HUMAN) used here was taken from an earlier study done 
by the lab7. hKDM5B PHD and hAIRE PHD were originally cloned into pGEX-4T3 
vector. hKDM5B PHD mutants (D331A, L325A, L326A) and hAIRE PHD mutant 
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(C310L) were created using site directed mutagenesis (refer to chapter 2). In total, 14 
proteins (4 wild types and 10 mutants) created in this section of the study are used to 
probe the peptide binding mechanisms of PHD finger subtypes. 
 
Table 3.1. Primers used for the Site Directed Mutagenesis of the subtype Proteins. The letter colored red is 
the site of mutation. Primers were purchased from Integrated DNA Technologies (IDT). 
Protein Forward Primer Reverse Primer Protein sequence 
UHRF1_Wildtype CGCGGATCCG 
GTCCGAGCTG 
CAAGCACTG 
CCGCTCGAGTT 
ACGCGTCGTTA 
CGGCATTCCG 
GPSCKHCKDDVNRLCR 
VCACHLCGGRQDPDK 
QLMCDECDMAFHIYC 
LDPPLSSVPSEDEWYCP 
ECRNDA 
UHRF1_D350A ATGTGCGACG 
AGTGCGCTAT 
GGCGTTCCAC 
ATC 
GATGTGGAAC 
GCCATAGCGC 
ACTCGTCGCAC 
AT 
GPSCKHCKDDVNRLCR 
VCACHLCGGRQDPDK 
QLMCDECAMAFHIYC 
LDPPLSSVPSEDEWYC 
PECRNDA 
UHRF1_L344A CAGGACCCGG 
ATAAGCAAGC 
GATGTGCGAC 
GAGTGCGAT 
ATCGCACTCG 
TCGCACATCG 
CTTGCTTATC 
CGGGTCCTG 
GPSCKHCKDDVNRLCR 
VCACHLCGGRQDPDK 
QAMCDECDMAFHIYC 
LDPPLSSVPSEDEWYCP 
ECRNDA 
UHRF1_M345A GACCCGGATA 
AGCAACTGGC 
GTGCGACGAG 
TGCGATATG 
CATATCGCAC 
TCGTCGCACG 
CCAGTTGCTT 
ATCCGGGTC             
GPSCKHCKDDVNRLCR 
VCACHLCGGRQDPDK 
QLACDECDMAFHIYC 
LDPPLSSVPSEDEWYC 
PECRNDA 
KAT6A_Wildtype CGCGGATCCC 
ACATGCTGGA 
GCTGCCGCAC 
CCGCTCGAGT 
TACGGACGGC 
AAATTTGGCA 
GATC 
HMLELPHEKDKPVA 
EPIPICSFCLGTKEQN 
REKKPEELISCADCG 
NSGHPSCLKFSPELT 
VRVKALRWQCIECK 
TCSSCRDQGKNADN 
MLFCDSCDRGFHME 
CCDPPLTRMPKGMW 
ICQICRP 
KAT6A_D285A TTCTGCGAC 
AGCTGCGCT 
CGTGGCTTT 
CACATG 
CATGTGAAAG 
CCACGAGCGC 
AGCTGTCGCA 
GAA 
HMLELPHEKDKPVA 
EPIPICSFCLGTKEQN 
REKKPEELISCADCG 
NSGHPSCLKFSPELT 
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VRVKALRWQCIECK 
TCSSCRDQGKNADN 
MLFCDSCARGFHME 
CCDPPLTRMPKGMW 
ICQICRP 
KAT6A_L279A GGTAAAAACG 
CGGATAACAT 
GGCGTTCTGC 
GACAGCTGC 
GCAGCTGTCG 
CAGAACGCCA 
TGTTATCCGCG 
TTTTTACC   
HMLELPHEKDKPVA 
EPIPICSFCLGTKEQN 
REKKPEELISCADCG 
NSGHPSCLKFSPELT 
VRVKALRWQCIECK 
TCSSCRDQGKNADN 
MAFCDSCDRGFHME 
CCDPPLTRMPKGMW 
ICQICRP 
KAT6A_F280A AACGCGGATA 
ACATGCTGGC 
CTGCGACAGC 
TGCGATCGT 
ACGATCGCAG 
CTGTCGCAGG 
CCAGCATGTT 
ATCCGCGTT     
HMLELPHEKDKPVA 
EPIPICSFCLGTKEQN 
REKKPEELISCADCG 
NSGHPSCLKFSPELT 
VRVKALRWQCIECK 
TCSSCRDQGKNADN 
MLACDSCDRGFHME 
CCDPPLTRMPKGMW 
ICQICRP 
KDM5B_Wildtype CGCGGATCC 
AATGCTGTG 
GACCTGTATG 
GAATGTAGT 
AAGCCACAA 
GAATAA 
CTCGAGCGG 
NAVDLYVCLLCGS 
GNDEDRLLLCDGC 
DDSYHTFCLIPPLH 
DVPKGDWRCPKCL 
AQECSKPQE 
KDM5B_D331A TGTGATGGCT 
GTGCGGACAG 
TTACCAT 
ATGGTAACT 
GTCCGCACA 
GCCATCACA 
NAVDLYVCLLCGS 
GNDEDRLLLCDGC 
ADSYHTFCLIPPLH 
DVPKGDWRCPKCL 
AQECSKPQE 
KDM5B_L325A AATGATGAAG 
ACCGGCTAGC 
GTTGTGTGAT 
GGCTGTGAT 
ATCACAGCCA 
TCACACAACG 
CTAGCCGGTC 
TTCATCATT 
NAVDLYVCLLCGS 
GNDEDRLALCDGC 
DDSYHTFCLIPPLH 
DVPKGDWRCPKCL 
AQECSKPQE 
KDM5B_L326A GATGAAGACC 
GGCTACTGGC 
GTGTGATGGC 
TGTGATGAC 
GTCATCACAGC 
CATCACACGCC 
AGTAGCCGGTC 
TTCATC 
NAVDLYVCLLCGS 
GNDEDRLLACDGC 
DDSYHTFCLIPPLH 
DVPKGDWRCPKCL 
AQECSKPQE 
AIRE- CGCGGATCC 
AAGAATGAG 
GACGAGTGTG 
CCGCTCGA 
GTTACTCC 
TGGACTGT 
KNEDECAVCRDG 
GELICCDGCPRAF 
HLACLSPPLREIPS 
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PHD1_Wildtype TGCCTG GTWRCSSCLQATVQE 
AIRE-
PHD1_C310L 
GACGGCGGGG 
AGCTCATCCT 
CTGTGACGGC 
TGCCCTCGG 
CCGAGGGCAG 
CCGTCACAGA 
GGATGAGC 
TCCCCGCCGTC 
KNEDECAVCRDG 
GELILCDGCPRAF 
HLACLSPPLREIPS 
GTWRCSSCLQATVQE 
 
 
Table 3.2. The cDNA UniProt ID and nucleotide sequence of the PHD finger subtype proteins 
cDNA UniProt ID Nucleotide Sequence 
hUHRF1 PHD (residues 299-367 
UniProt ID 
Q96T88/UHRF1_HUMAN) 
GGTCCGAGCTGCAAGCACTGCAA 
AGACGATGTGAACCGTCTGTGCC 
GTGTTTGCGCGTGCCACCTGTGC 
GGTGGCCGTCAGGACCCGGATAA 
GCAACTGATGTGCGACGAGTGCG 
ATATGGCGTTCCACATCTATTGCC 
TGGACCCGCCGCTGAGCAGCGTG 
CCGAGCGAGGATGAATGGTATTG 
CCCGGAATGCCGTAACGACGCG 
hKAT6A DPF (residues 196-319 
UniProt ID 
Q92794/KAT6A_HUMAN) 
CACATGCTGGAGCTGCCGCACGAA 
AAGGACAAACCGGTGGCGGAGCCG 
ATCCCGATTTGCAGCTTCTGCCTGG 
GTACCAAGGAGCAGAACCGTGAAA 
AGAAACCGGAGGAACTGATCAGCTG 
CGCGGATTGCGGTAACAGCGGCCAC 
CCGAGCTGCCTGAAGTTTAGCCCGG 
AGCTGACCGTGCGTGTTAAAGCGCT 
GCGTTGGCAGTGCATTGAATGCAAG 
ACCTGCAGCAGCTGCCGTGACCAAG 
GTAAAAACGCGGATAACATGCTGTT 
CTGCGACAGCTGCGATCGTGGCTTTC 
ACATGGAATGCTGCGACCCGCCGCTG 
ACCCGTATGCCGAAAGGCATGTGGAT 
CTGCCAAATTTGCCGTCCG 
hKDM5B PHD (residues 305-366 of 
UniProt ID 
Q9UGL1/KDM5B_Human) 
AATGCTGTGGACCTGTATGTCTGTCTTT 
TATGTGGCAGTGGCAATGATGAAGACC 
GGCTACTGTTGTGTGATGGCTGTGATGA 
CAGTTACCATACCTTTTGCTTGATCCCAC 
CTCTCCATGATGTTCCCAAGGGAGACTGG 
AGGTGTCCTAAGTGTTTGGCTCAGGAATG 
TAGTAAGCCACAAGAA 
hAIRE PHD (residues of 294-343 
UniProt ID O43918/AIRE_HUMAN) 
AAGAATGAGGACGAGTGTGCCGTGT 
GTCGGGACGGCGGGGAGCTCATCTG 
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CTGTGACGGCTGCCCTCGGGCCTTCC 
ACCTGGCCTGCCTGTCCCCTCCGCTC 
CGGGAGATCCCCAGTGGGACCTGGAG 
GTGCTCCAGCTGCCTGCAGGCAACAG 
TCCAGGAG 
 
 
Expression and purification of proteins and their Mutants 
          The recombinant subtype PHD finger proteins and their mutants were purified as 
described in chapter 2. Briefly, E. coli BL21 (DE3) cells expressing the protein from 
pET28a vector were induced at OD600 = 0.6-1.0 with 1 mM IPTG grown overnight at 
16°C. The fusion proteins were isolated using His-tag affinity chromatography. The 
proteins were then purified to homogeneity by gel filtration using HiLoad 26/600 
superdex column using FPLC. Protein purity was confirmed by SDS-PAGE. 
Recombinant hUHRF1 PHD and its mutants (L344A, M345A, and D350A), hKAT6A 
DPF and its mutants (L279A, F280A, and D285A) were all purified similarly as 
described for hBAZ2A PHD following the His-tag affinity chromatography step. 
Recombinant hKDM5B PHD and its mutants (D331A, L325A and L326A) were purified 
as described in Chakravarty et al. 7 using the pGEX-4T3 vector constructs. Similarly, 
recombinant hAIRE PHD and its mutant (C310L) were purified using the pGEX-4T3 
vector constructs. Briefly, the fusion proteins were isolated using GST affinity 
chromatography (Pierce glutathione agarose, Thermo scientific). GST tag was eliminated 
by overnight human alpha thrombin (Haematologic Technologies) digestion at 4°C prior 
to FPLC. Remaining purification steps were same as that of the hBAZ PHD in chapter 2. 
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            A                                               B 
	  
                                   C                                              D 
	  
Figure 3.3. (A-D) Chromatograms showing the FPLC profile peaks of purified hUHRF1-PHD, (A) 
Wildtype, (B) D350A, (C) L344A, and (C) M345A respectively. All the proteins were eluted with 100ml 
150mM imidazole in 1x phosphate buffer and concentrated to 4ml before loading into the AKTA prime 
FPLC at 4°C. The tubes corresponding to the peaks were concentrated to 0.1mM for the ITC measurement. 
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          A                                                      B 
	  
           C                                                         D 
	  
Figure 3.4. (A-D) Chromatograms showing the FPLC profile peaks of purified hKAT6A-PHD, (A) 
Wildtype, (B) D285A, (C) L279A, and (D) F80A respectively. All the proteins were eluted with 100ml 
150mM imidazole in 1x phosphate buffer and concentrated to 4ml before loading into the AKTA prime 
FPLC at 4°C. The tubes corresponding to the peaks were concentrated to 0.1mM for the ITC measurement. 
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 A                                                      B 
	  
                   C                                               D 
	  
Figure 3.5A. (A-D). Chromatograms showing the FPLC profile peaks of purified hKDM5B-PHD, (A) 
Wildtype before GST cleavage, (B) Wildtype after GST cleavage, (C) D331A mutant before GST cleavage 
and (D) D331A mutant after GST cleavage. 
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               E                                                F 
	  
                 G                                                H 
	  
Figure 3.5B. (E-F). Chromatograms showing the FPLC profile peaks of purified hKDM5B-PHD mutants, 
(A) L325A mutant before GST cleavage, (B) L325A mutant after GST cleavage, (C) L326A mutant before 
GST cleavage and (D) L326A mutant after GST cleavage. 
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Figure 3.6A. Chromatograms showing the FPLC profile peaks of purified hAIRE-PHD1 wild type. (Top) 
Before GST cleavage (Bottom) After GST cleavage 
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Figure 3.6B. Chromatograms showing the FPLC profile peaks of purified hAIRE-PHD1 C310L Mutant. 
(Top) Before GST cleavage (Bottom) After GST cleavage 
 
Synthetic Peptides  
          We used two synthetic peptides for this section of the study. They are: (i) Histone 
H3 residues 1-11 (H3-1-11W), and (ii) Histone H3 residue 1-16 with acetylation at K14 
(H3K14ac-1-16W). The W in the synthetic peptide sequence represents C-terminal 
Tryptophan residue. H3-1-11W was used for the binding studies of the wild type and the 
mutants of hUHRF1 PHD and hKDM5B PHD proteins. H3K14ac-1-16W peptide was 
used for the binding studies of the wild type and the mutants of hKAT6A DPF. 98% pure 
(confirmed with mass-spec) synthetic peptides were obtained from GeneScript. The C-
terminal Tryptophan residue in the peptide was used for estimating peptide 
concentrations by absorbance using the computed molar extinction coefficient66. These 
peptides were used for ITC (Isothermal Titration Calorimetry) experiments. While this 
work was in progress we had learned that hKAT6A DPF binds crotonylated H3K14cr-1-
25 peptide with the highest affinity (Kd = 5.8µM)24 that is ~4.0 fold higher than that for 
the H3K14ac peptide. Though we realize that it would have been ideal to have the 
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peptide mutational analysis for hKAT6A DPF in the crotonylated H3K14cr-1-25 peptide 
background, we carried out our experiments based on the earlier structural report of 
hKAT6A DPF in complex with H3K14ac-1-1681. The ITC experiments, reported in the 
earlier study of the interaction of hKAT6A DPF with H3K14ac-1-1681, were carried out 
in 50 mM NaCl, while our ITC experiments were all performed at 150 mM NaCl. Under 
these conditions, we do not observe the difference in the binding enthalpy between H3-1-
16 and H3K14ac-1-16 peptides reported earlier81.  
 
Alignments, PHD subtypes and Occurrence Frequency 
          10,858 PFAM-aligned sequences of PHD finger superfamily (PFAM82 accession 
number PF00628.26) in STOCKHOLM 1.0 format were manually downloaded from the 
PFAM ftp server. This alignment was first condensed by eliminating the alignment 
positions having the symbol “.” in the original PFAM-alignment. The eliminated 
positions in this step have the symbol “.” greater than 85% of times in the alignment 
column. Sequences are extracted from the condensed alignment for creating a non-
redundant set. Using CD-Hit83, redundant sequences at 85% sequence identity were 
eliminated. The final non-redundant set contained 3,469 sequences. A part of the 
condensed master PFAM-alignment of these 3,469 sequences is shown in Figure 3.7. In 
this master alignment, the correspondence between residues in the original PFAM 
alignment is not altered even though redundant sequences were eliminated. Without 
altering the master alignment, PHD sequences are further segregated into subtypes 
(Figure 3.7). A breakdown of these 3,469 sequences into subtypes: (i) PHD_W subtype 
(1,425 sequences), and (ii) PHD_nW subtype (2,044 sequences). The PHD_nW subtype 
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sequences were further segregated into: (a) PHD_nW_DD (692 sequences), (b) the 
remaining 1362 PHD_nW sequences. PHD_nW_DD subtype refers to PHD_nW 
sequences having a pair of Asp residues in the treble-clef knuckle of the PHD scaffold. 
As described in Chakravarty et al.7, double PHD finger (DPF) scaffolds belong to this 
subtype, and therefore, are categorized as a distinct subtype. As a control for the 
PHD_nW_DD subtype, PHD_W subtype sequences were also segregated into: (a) 
PHD_W_DD (234 sequences) and (b) the remaining 1191 PHD_W sequences. 
PHD_W_DD subtype refers to PHD_W sequences having a pair of Asp residues in the 
treble-clef knuckle of the PHD scaffold. As all of these groups are extracted from the 
same condensed master PFAM-alignment, the alignment positions in each subtype 
remain the same (Figure 3.7), and therefore, enable comparison of position specific 
statistics among the subtypes. For example, Occurrence frequencies of residues at L1 and 
L2 positions are calculated based on the 85% non-redundant master PFAM alignment and 
the same alignment when partitioned into subtypes (Figure 3.7). Segregating the 
sequences into subtypes was carried out by simply extracting sequences that met the 
residue-type selection criterion for an alignment position, e.g. selecting sequences with 
residue W/Y/F for the 26th position in the PFAM alignment (Figure 3.1) resulted in 
PHD_W subtype and the remaining sequences are considered PHD_nW. Similarly, 
selecting PHD_nW sequences with residue D at the 24th position in the PFAM alignment 
(Figure 3.1) resulted in PHD_nW_DD subtype. The frequency of occurrence (pji) of the 
jth amino acid (or residue type) in the ith alignment position (column) is the ratio 
between the number of times the jth residue type appears in the ith alignment position 
and the total number of sequences in the alignment (e.g. subtype alignment). Entropy for 
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the ith position in this alignment was computed as, Entropy i = 4.39 - Σ (pji)×(log2 (pji)), 
where pji is the probability of the jth amino acid at the ith alignment position (column) 
and 4.39 is the value of maximum entropy. Entropy and pji for each PHD-subtype and 
the PHD superfamily are calculated separately using the subtype specific alignments 
shown in Figure 3.7.  
 
SUPPELMENTARY FIGURE S2
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I1F6U8_AMPQE/405-464   s-CPVCGElDNDFDSKMVQCSQCDNWVHSHCENMTDEEYEILSDvEYVCRLCI--ay
F7EPF7_CALJA/874-933   .YCPICTReDNDYESKMMQCAQCDHWVHAKCEGLSDEDYEILSGvLYTCGPCA--ga
G3TDX0_LOXAF/1477-1539 .FCPLCDKdDDDYESKMMQCGKCDRWVHSKCENLSGTEDEMYEIvAYTCVNCTE-r.
D3BN85_POLPA/480-537   .YCSVCRKiKPHEKSPTIQCGYCDRWTHSQCDGMSVSNLEKFKDhQYKCQACRN-g.
B6ABB5_CRYMR/769-825   .YCAICRQwSSSWDGDWLQCDTCRFWIHTECDTNLINSIEVLKSvSYHCPVCRS-n.
H2LPY8_ORYLA/455-514   y-CPICFKeDNDYDSQMMQCGTCNHWVHAKCEDLTDELYEILSSvVYSCRPCS--vt
C1EJ22_MICSR/354-412   .RCVTCEQdRVEKPGQMLRCDGCGDWHHAECAAFDPTDSGIVRGtSFVCVRCR--da
M4FIA9_BRARP/340-394   n-CGICKRgNHLDRQTWVKCDGCKVWVHVECDKTSDKHLKGLGEtDYYCPTCRA-k.
F1QKR5_DANRE/1126-1185 y-CTMCFKeDNDYDSQMMQCSTCNHWVHAKCEGLTDDLYEILSSvVYSCQPCLK-e.
F6XZK4_XENTR/170-229   f-CPICIReESEYESKMIQCAKCDKWIHSKCEGLSDEGYELLSNvVYTCPPCL--gn
G7I4B1_MEDTR/406-460   .YCGICKKwNQSDSGSWVRCDGCKVWVHAECDKISSILFKNLGStDYFCPACKV-k.
ATX3_ARATH/364-418     .YCGICKRwHPSDDGDWVCCDGCDVWVHAECDNITNERFKELEHnNYYCPDCKV-q.
H2AUD0_KAZAF/48-109    .RCPVCGTaENDPYGDMIQCDGCDAWQHINCMTGGKKDIKAFLDgKYFCEQCDP-q.
M2R555_CERS8/788-847   d-CEICHKvNVDDSQPMVSCGRCARWQHIPCHDAADQRLGRPKRgQFYCSRCRA-a.
F4PL42_DICFS/616-675   .YCTVCRKkSSGEKKPIVQCVYCDRWTHAGCDSITEEFLEKMKEhQYKCPTCKT-g.
B0DAJ4_LACBS/561-620   d-CEICQRvNLDDGTPMMSCESCAKWQHILCHDKADRAAGRRRRvEFICEKCRR-a.
G0WI25_NAUDC/51-112    .RCPVCGTpNTDTNGDMVQCDGCDMWQHIKCMTGGLEDIESLLTrKYFCEKCDP-t.
M0XBH6_HORVD/267-324   .YCPVCLKyRDSEVIPMVCCDVCEKWVHIECDGISEEKYQQFQAlQYTCASCR--ge
E6ZUY3_SPORE/579-641   n-CEVCGKsPPDEDNEIVCCEQCGVWQHIKCWDAFDKQIIGLKKeDFFCSKCRP-p.
L5K3T6_PTEAL/401-455   l-CPFCGKyHPELQKDMLHCNMCKRWVHLECDKPADHELDSPFReEYVCTYCK--hv
H2XVG1_CIOIN/17-70     l-CSVCGSsQEVTQSPWIGCDICFRWYHRKCINVPKKSFEHVKIeEWKCPVCIC-h.
S7RIH9_GLOTA/714-775   h-CEVCRKiNIDNDVPLVQCEVCKKWQHQQCHDRVDEANGRRRRyHFMCQACQP-t.
---------------------- ---------------------------------------------------------
      ---------------------------------------------------------
L8Y4J2_TUPCH/205-272    .YCDFCLGkKSGRPEELVSCADCGRSGHPTCLQFTLNMTEAVKTyKWQCIECKSCil
I1F6U8_AMPQE/405-464    s-CPVCGElDNDFDSKMVQCSQCDNWVHSHCENMTDEEYEILSDvEYVCRLCI--ay
U4UN85_DENPD/154-212    .ICCGCLGdHSDGVNEIVECDSCGVTVHEACYGISDSNSLASTNaPWFCETCR--ag
G4MKY4_MAGO7/421-475    p-CKACGRiADTKTNLIVFCDGCNYAWHQNCHTPNIDDSFINEMkAWHCVGCAT-k.
F7EPF7_CALJA/874-933    .YCPICTReDNDYESKMMQCAQCDHWVHAKCEGLSDEDYEILSGvLYTCGPCA--ga
M4D1G0_BRARP/189-244    .FCAECNSrEASLDNDIILCDGCNRAFHQKCLDPPLETESIPPGqGWFCKICDCK..
G3TDX0_LOXAF/1477-1539  .FCPLCDKdDDDYESKMMQCGKCDRWVHSKCENLSGTEDEMYEIvAYTCVNCTE-r.
H2UAS1_TAKRU/214-271    .ICSFCLGnRDKQPEELLSCADCGSSGHPSCLKFSPELTSNVKRlRWQCIECKTC..
F7A7X5_CALJA/272-330    .YCDFCLGkKTGQPEELVSCSDCGRSGHPSCLQFTPVMMAAVKTyRWQCIECKCC..
G3W811_SARHA/273-332    .ICCVCLGdNSEDADEIIQCDNCGITVHEGCYGVDGESDSIMSSePWFCDACKC-g.
D3BN85_POLPA/480-537    .YCSVCRKiKPHEKSPTIQCGYCDRWTHSQCDGMSVSNLEKFKDhQYKCQACRN-g.
B6ABB5_CRYMR/769-825    .YCAICRQwSSSWDGDWLQCDTCRFWIHTECDTNLINSIEVLKSvSYHCPVCRS-n.
A8X7Y2_CAEBR/261-319    n-CDFCNGkNSRLPEDLVSCHDCGRSGHPSCMSFNQNVTMIIKRsGWQCLECKSC..
B4KLS0_DROMO/382-440    .YCDFCLGkKTNMPEELVSCSDCGRSGHPSCLQFTPNMIISVKRyRWQCIECKY-c.
H2LPY8_ORYLA/455-514    y-CPICFKeDNDYDSQMMQCGTCNHWVHAKCEDLTDELYEILSSvVYSCRPCS--vt
E9CZE5_COCPS/329-383    t-CEHCQRgHSPSGNPIVFCDDCNGGWHRFCHDPPIEVEVVNVKsQWFCRACRP-v.
B3RUC0_TRIAD/188-245    .ICSFCLQnRSNEYEELLSCVDCGNSGHPSCLKYSPELTSRVKTePWQCIECKTC..
H0WE18_CAVPO/272-327    .YCDFCLGkKTGCPEDLISCADCGRSGHPSCLQFTVNMTAAVRTyRWQCIECKSC..
T1K1Q6_TETUR/250-308    .YCDFCLGkKTASAEKMISCSDCGRSAHPTCLQFTPRMVTSIKKyRWQCIECKSC..
G3HED2_CRIGR/2-55       .VCTICQEeYSEAPNEMVICDKCGQGYHQLCHTPHIDSSVIDSDeKWLCRQCV--fa
C1EJ22_MICSR/354-412    .RCVTCEQdRVEKPGQMLRCDGCGDWHHAECAAFDPTDSGIVRGtSFVCVRCR--da
E9GAC6_DAPPU/86-139     s-CILCKSiQSTSSNKILLCHYCRRGYHQSCHEPALPSQFANGEtNWLCMRCME-k.
V4ABW2_LOTGI/14-71      v-CSYCKLnTKGKPEKLLVCQDCKTTAHPSCMKYSPKLAKKAYKgVWQCIDCKSC..
H3AIB3_LATCH/399-456    .ICGICLNnKKGKPEALIHCSQCHNSGHPSCLDMSVELVSVIKTyPWQCMECKTC..
M4FIA9_BRARP/340-394    n-CGICKRgNHLDRQTWVKCDGCKVWVHVECDKTSDKHLKGLGEtDYYCPTCRA-k.
K7MBU2_SOYBN/289-344    .FCANCKLhEAFPDNDIILCDGCNRAFHQRCLNPPLDTENIPPGqGWFCKFCECK..
--------------------    ---------------------------------------------------------
--------------------    ---------------------------------------------------------
PFAM alignment 
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B4KLS0_DROMO/382-440   .YCDFCLGkKTNMPEELVSCSDCGRSGHPSCLQFTPNMIISVKRyRWQCIECKY-c.
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V4ABW2_LOTGI/14-71     v-CSYCKLnTKGKPEKLLVCQDCKTTAHPSCMKYSPKLAKKAYKgVWQCIDCKSC..
H3AIB3_LATCH/399-456   .ICGICLNnKKGKPEALIHCSQCHNSGHPSCLDMSVELVSVIKTyPWQCMECKTC..
K7MBU2_SOYBN/289-344   .FCANCKLhEAFPDNDIILCDGCNRAFHQRCLNPPLDTENIPPGqGWFCKFCECK..
U3JGH1_FICAL/151-204   k-CSICLGkKSGPRNEILICGKCGLGYHQQCHIPVASGGEGPLGtPWFCRRCI--fa
T1HBJ4_RHOPR/379-436   k-CKICKTgKDAQMEPLIQCAQCKTTTHPSCQDFTDEMLPHIKKyNWLCTDCKQC..
C1MVF1_MICPC/178-233   .FCCACGDgESTDDNDILLCDGCDRGFHQRCCVPPVRTEDIPEGeGWLCALCDA-r.
T1JU09_TETUR/295-353   .YCDFCLGkKSRSREKMVSCSDCGRSAHPTCLQFTAQMILAVQKyRWQCIECKSC..
---------------------  ---------------------------------------------------------
PHD_W subtype PHD_nW subtype
21
D1
24
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19
L2
21
D1
24
D2
A
D
24
C1MVF1_MICPC/178-233   .FCCACGDgESTDDNDILLCDGCDRGFHQRCCVPPVRTEDIPEGeGWLCALCDA-r.
W5ACS9_WHEAT/224-279   .VCATCSLqEATFNNDIILCDGCDRGFHQNCLNPPLLTKDIPEGeGWLCPACDCK..
F6WAN9_CIOIN/400-457   .VCGICSKnKKGEAEELIKCSQCDNHGHPSCLEMSVEQVSVIETyNWQCMECKTC..
K7N378_SOYBN/344-399   .FCAKCQSkELSTNNDIILCDGCDRGFHQLCLDPPLLTEDIPPGeGWLCPGCDCK..
D7L9Z9_ARALL/262-317   .FCAKCGSkDLSVDNDIILCDGCDRGFHQYCLEPPLRKEDIPPDeSWLCPGCDCK..
B2AN43_PODAN/276-330   l-CKKCSRmHSPSSNQIVFCDGCDAGWHQYCHDPFVSDDIVKNTkNWFCSECAA-k.
B3RYM1_TRIAD/72-125    a-CKTCHGeVSEVPNLIVICDNCDQGYHQKCHIPQVSDSLLKPDiQWICRYCI--fg
J3KVP8_ORYBR/246-301   .FCAICSSkDVTLKNDIILCDGCDRGFHQYCLNPPLLAEHIPPGeGWLCPACDCK..
A4SB05_OSTLU/87-142    .FCSKCAMaDDREEDDILLCDGCDRAYHQSCVVPAVKTEDIPPDeGWLCPLCDA-r.
M0SUT5_MUSAM/128-183   .FCAKCGSkDLSADNDIILCDGCDRGFHQKCLNPPLATDEIPPGqGWLCPACDCK..
T1FJT5_HELRO/4-61      k-CAKCLGtNVKDKDSVLRCSRCDTVVHVKCISTNDSLLDALKNlKWFCDGCV--kl
H2Z2E7_CIOSA/17-74     l-CDFCLKnRLGEFEQMLFCKDCDAKAHPSCMKYSSTLAFKALTyPWQCVECKTC..
U9TI31_RHIID/338-392   v-CTICCDgTSAKQNWIVFCDKCDAPYHQLCHKPKIEDIVVQDStEWICAKCKI-s.
F6H698_VITVI/310-365   .FCAKCESkDMSADNDIILCDGCDRGFHQFCLEPPLLKEEIPPDeGWLCPACDCK..
S8AKJ7_DACHA/167-221   s-CMVCTRtPDSPEDQIVFCDGCDQAYHQYCHVPIIDNSFVQMAkNWYCKNCEP-g.
U9UVV7_RHIID/156-210   .VCIICHDgNSPKHNRIVLCDKCDTPYHQRCHKPSIENREIPDA.EWICSKCD--dl
D7L369_ARALL/151-203   .MCVVCQStDGDPSNPIVFCDGCDLMVHASCYGNPLV-KAIPEG.DWFCRQCIS-sk
R1DEX7_EMIHU/6-58      c-CNVCGEgDWEEDNKIIFCDSCDLAVHQVCYGAGARVIPEGDA.PWFCDMCKF-s.
F1SC00_PIG/379-435     l-CGICLRnKRGKAEPLVHCSQCDSSGHPSCLDMSVELVSVIKTyPWQCMECK--t
--------------------   ---------------------------------------------------------
--------------------   ---------------------------------------------------------
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Figure 3.7. Master pfam alignment of PHD subtypes: (A) PFAM alignments of non-redundant (85% 
sequence identity) PHD finger sequences (top) are further segregated into subtype specific sequences 
(middle row and bottom). Sequences in the middle row subtypes are grouped based on the position number 
‘26’ as having W/aromatic-residue (left, PHD_W subtype) and not having W/aromatic-residue (right, 
PHD_nW). The bottom row sequences (PHD_nW_DD subtype) are extracted from PHD_nW with the 
position number ‘24’ as having D. (B) The distributions of sequence identity in each subtype with the 
dashed lines representing the median of sequence identity for each subtype. 
 
          The sequence logo (e.g., Figure 3.2, 3.15 and 3.17) was created using the online 
version of the Skylign program84 by uploading PHD subtype specific alignments. For 
sequence identity distribution (Figure 3.7B), sequence identity between sequences, i and 
j, was calculated by comparing residue identity between the aligned positions of master 
alignment. The observed median of the sequence identity distributions (Figure 3.7B, 
dashed line) of a subtype (e.g. PHD_nW_DD) was used to set the sequence identity 
cutoff (≤ 40%) for structural analysis.   
          All structural alignments and structural superposition operations (e.g., Figure 3.2, 
3.8, 3.21), discussed here, were generated using MUSTANG85. MUSCLE86 sequence 
alignment was also used for aligning: (a) double PHD finger (DPF) sequences (Figure 
3.1A) with the remaining PHD_nW_DD sequences, and (b) sequences of a PFAM 
domain with the GREMLIN87, 88 consensus sequence of the PFAM domain (see below, 
Figure 3.8C). The sequences of the DPFs were first compiled as described earlier7 and the 
sequences with 85% identical residues were eliminated after MUSCLE alignment.    
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Mutual Information and PFAM domains  
          The mutual information (MI) of a residue pair of PFAM domain alignments was 
calculated using the MISTIC89 web server by manually uploading the master PFAM 
MSA (see above) in fasta format. The server calculates MI between pairs of columns in 
the MSA. The calculation of frequency for each amino acid pair uses sequence weighting 
and low count corrections in addition to comparing the computed frequency to the 
expected pair-frequency with the assumption that the amino acids are non-correlated90. 
The MI is represented as a weighted sum of the log-ratios between the observed and 
expected amino acids pair frequencies90.  
          The server returns an MI value for each pair of residue positions in an MSA89. The 
server also returns a cumulative mutual information score (CMI) for each MSA position 
as the sum of MI values above a certain threshold (measured in terms of the MI Z-
score91) for every amino acid pair where the particular residue appears. The CMI value 
represents the degree of participation of a given MSA position in the mutual information 
network91. The scores returned by the server correspond to positions of the first sequence 
in the alignment. For convenience, in all our alignments for MI calculations by the 
MISTIC server, the first sequence was reserved for the protein of interest having a known 
structure, e.g. BAZ2A PHD in the PHD alignments. For the PDZ domain (PFAM 
accession number PF00595.71), Drosophila inactivation-no-after-potential (InaD) protein 
(INAD_DROME, pdbid: 1ihj) was used as the first sequence for MI analysis. An earlier 
large-scale mutational analysis of PDZ peptide binding site had noted that 16-18 
positions around the binding site confer binding specificity40. The binding site in that 
study was defined by PDZ pdbids (1ihj, 1n7t, 2h2b, 1i92, etc.), and therefore, we used 
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1ihj (INAD_DROME) as reference sequence as its structure is in complex with the 
peptide. We used these 16-18 residue positions of INAD_DROME around its binding site 
as a representative of the PDZ binding site (Figure 3.22A). To avoid confusion, the 
residue numbering is that of INAD_DROME (Figure 3.22A, B, C), and for convenience, 
their correspondence to PDZ family alignment is indicated in Figure 3.22B. The MI score 
text file was reformatted as a matrix for creating MI density plot (e.g., Figure 3.21B, 
3.22A) using the Matrix2png92 program. For display of the CMI scores mapped onto the 
structure, the CMI score of a residue replaced the b-factor column of the corresponding 
residue in the coordinate file. The 85% non-redundant alignments of PHD, PDZ and 
Bromodomains (PFAM accession number PF00439.22) respectively had 3469, 4950 and 
3477 sequences. For MI calculation of artificial sequences (see below), a set of 1000 
sequences was used, and for PHD, BAZ2A sequence was once again placed at the first 
sequence among the set of 1000 artificial sequences. 
 
GREMLIN restraint score analysis 
          The pre-computed GREMLIN results (residue pair covariance and the consensus 
sequence) of each PFAM domain were manually downloaded from the GREMLIN87, 88 
webserver. The GREMLIN result text file, consisting residue pair covariance 
information, contains three scores: (i) raw score (r_sco), (ii) scaled score (s_sco), and (iii) 
probability score (prob). The scaled score (s_sco) represents covariance normalized 
among the residue pair scores of a PFAM domain family87, 88. These paired scores 
correspond to residues of GREMLIN consensus sequence. We use MUSCLE alignment 
(see above) to get the correspondence between residues of the GREMLIN consensus 
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sequence and the sequence of protein of interest (Figure 3.8C). GREMLIN also imposes 
a sequence separation cutoff of 3 residues for a pair of residues to have covariance score. 
Therefore, we do not have s_sco score for the D2−W pair, as the sequence separation is 2 
in the PHD alignment (Figure 3.21B). A residue can have more than one s_sco score as it 
can be in contact with several residues, and the highest s_sco score of a residue was 
mapped on to the structure by manipulating the b-factor column of the coordinate file 
(Figure 3.8A). The root mean squared deviation (RMSD) of Cα-atoms between the 
corresponding positions in MUSTANG structural alignment is mapped to the structure by 
replacing the b-factor column with the RMSD. PFAM domain structures with resolution 
better than 2.2Å and having a sequence identity ≤ 40% with each other were considered 
for the GREMLIN−RMSD analysis (Figure 3.8B). Even though there are several new 
structures available for the PFAM domains analyzed here, for the GREMLIN−RMSD 
analysis, pdbids listed as “DR PDB” record within the header of pfam alignment file in 
STOCKHOLM 1.0 format were used for the convenience of running automated scripts, 
and the PFAM alignment files were downloaded in 2015 November. 
          GREMLIN restraints for other PFAM peptide-binding domains (e.g., the PDZ 
domain and bromodomain) were also examined for a comparative study. Here we utilized 
the normalized GREMLIN restraint score (s_sco, see above) to map on to the structure to 
visually infer the relative contributions of residues to folding (Figure 3.23A). Compared 
with other PHD positions, the s_sco scores of the binding-site positions (including W, L2, 
and D2) rank high (Figure 3.23A). In comparison, the s_sco scores of regions remote 
from the binding site in the PDZ domain and bromodomain (Figure 3.23A) are higher 
than that of the respective binding sites. This could also be attributed to the larger size of 
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the PDZ domain (~80 residues), the bromodomain (~85 residues). Compared with the 
~50-residue PHD scaffold, PDZ and bromodomain have many more inter-residue 
contacts, which are necessary to fold the scaffold. The PHD peptide-binding site is also 
positioned between two Zn-chelation centers, the key folding nucleus of the scaffold. The 
higher s_sco score for binding-site residues of the PHD scaffold is therefore likely 
justified. Consistent with the GREMLIN score, a comparison of the RMSD of crystal 
structures of PFAM domain members sharing less than 40% sequence identity shows that 
the structural deviation of the PHD peptide-binding site is smaller (Figure 3.23B). 
 
Figure 3.8. Context dependent conformations of the H3 peptide: Structural representations of the 
conformations of histone H3 involving regular (mediated by backbone hydrogen bonds) as well as non-
regular secondary structures. This structural malleability of the disordered histone H3 segment thus likely 
contributes to the one-to-many interactions93 of chromatin network hubs. Protein names and pdb ids are 
RBB4 (2yba)
H3-1-15
SFG29 (3met)
H3-1-8
SAWADEE (4iur)
H3-3-10
ATRX (3qla) UHRF1 (3ask)
H3-1-9
H3-1-10
KAT6A (5b75)
H3-1-25
Context Dependent Conformations  of H3
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indicated. The role of H3T3 OG1 atom as N-cap is also observed in other H3 complexes. Additional factors 
(other than those listed in Figure 3.18D bottom) might play important role in the context dependent 
conformations of the H3 peptide. For example, with UHRF1, only the first helical turn of H3 is observed 
where the tandem tudor domain (TTD) anchors the H3K9me3 residue, while 3 helical turns are observed 
with DPFs where PHD1 of DPFs anchor the alkylated H3K14 residue. 
 
Perturbed and Artificial Sequences  
          The multiple sequence alignment (MSA) of a PFAM domain consisting of 85% 
non-redundant sequences is considered as the master MSA of the family. We consider a 
position/column of a multiple sequence alignment (MSA) to be perturbed when we 
permit only a specific type of residues to appear in that column. For example, W position 
of PFAM PHD alignments (Figure 3.7, left) is perturbed when we permit only W, Y and 
F to appear at the W position. The set of sequences that meets the condition is considered 
here to be perturbed. Thus, PHD_W is considered to consist of perturbed sequences. 
Mentioned above, the perturbed sequences retain the same alignment as that of the master 
MSA. The occurrence frequency of amino acids in a column of the master alignment is 
referred to as probability while that of a perturbed alignment as conditional probability, 
i.e. a condition is imposed on the observed probability. The conditional probability of an 
amino acid in a column is compared with its probability in the corresponding column as, 
p = (conditional probability)  (probability) (see Figure 3.9A). For p, a positive 
value is considered as positive enrichment () and a negative value is considered as 
negative enrichment () (Figure 3.9A, 3.7C). For convenience, p is calculated for the 
most frequent amino acid in a column. The probability of the most frequent residue at 
each master PHD alignment position is shown in Figure 3.10A (right, top) and the 
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corresponding conditional probability when perturbed by the D2 position in Figure 3.10A 
(right, middle) as an example. We note negative enrichment for the W position when 
perturbed by positions characteristic of the PHD_nW_DD subtype (Figure 3.9A, 3.10A 
bottom). To avoid confusion, W and G positions refer to the same position, and a positive 
enrichment of W is always associated with negative enrichment of G or the vice versa. As 
PHD_nW_DD do not have W in the W-position, but a G, we use both symbols in the 
discussion. We were cautious in interpreting enrichment for regions with a poor quality 
of alignment. For example, the quality of alignment in the region housing BAZ2A 
V1713, particularly, in the PHD_W group is less reliable (Figure 3.19B, 3.19D). This is 
due to the insertions and deletion, as can be noted with PHD_W structures having helices 
of varying lengths in this region (Figure 3.17D). Therefore, the estimate of occurrence 
frequency of specific nonpolar residue (p = 0.23) for this region in the PHD_W subtype is 
less reliable (Figure 3.19B). 
          We generated artificial sequences in the following manner. Amino acids, in the row 
positions of each column of the master alignment, are assigned randomly such that the 
probability of occurrence of an amino acid in that column remained the same as that of 
the master alignment. In one iteration, 1,000 artificial sequences were generated, and 100 
iterations were carried out. The following two conditions were checked: (i) E-value of an 
artificial sequence was lower than a preset value (Figure 3.11A), and (ii) ΔEntropy (the 
numerical difference between the entropy of the corresponding columns in the alignments 
of artificial and natural sequences) was lower than a preset value (Figure 3.10C, right). 
The E-value of sequences was calculated by hmm2search of HMMER294 package using 
PFAM PHD hmm. The set of 1,000 artificial sequences were perturbed similarly, and the 
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probability and conditional probability of the most frequent amino acids in the 
corresponding columns of artificial and perturbed artificial sequences calculated (Figure 
3.10B, C). In Figure 3.10B (right), the vertical arrow represents the conditional 
probability of the indicated position when perturbed by the D2 position while the 
horizontal arrows indicate the direction of the deviation of the conditional probability 
obtained from artificial sequences from that obtained from real sequences. The direction 
of the horizontal arrow also indicates, positive enrichment (right-hand direction) and 
negative enrichment (left-hand direction). 
 
Figure 3.9. Reciprocal enrichment and mutual information (MI) of PHD: (A) The occurrence frequency 
(black bar) at an indicated position is altered (gray bar) as a result of perturbation. The gray bars represent 
change in frequency (Dp) with respect to the horizontal line (black bar height). The perturbed positions are 
indicated with encircled smaller fonts while encircled larger fonts represent positions undergoing frequency 
change. For convenience, the most frequent amino acid at each position in the 85% non-redundant PFAM 
and corresponding BAZ2A PHD sequences are at the top.  (B) The mutual information (MI) between 
	
	
	
81	
positions in the PHD finger family. The CMI score for each position is at the top and the matrix represents 
the MI scores between positions. The distribution of the MI values (left) and the GREMLIN s_sco values 
(right) between positions are at the bottom.    
 
 
Figure 3.10. Characteristics of PHD Natural and artificial sequences: (A) The characteristics of each 
position of the aligned PHD natural sequences are categorized by entropy (left panel) and occurrence 
--C-VCGK---DDDGEMLLCDGCDRWYHLYCLGPPLE--EVPEG-DWFCPECR--K-
4
3
2
1
En
tr
op
y
80%
4
3
2
1
En
tr
op
y
10 20 30 40 50
1.0
|Δ
En
tr
op
y|
0.5
0.0
10 20 30 40 50
--C-VCGK---DDDGEMLLCDGCDRWYHLYCLGPPLE--EVPEG-DWFCPECR--K-
PHD pfam reference
1.00
0.75
0.50
0.25F
re
qu
en
cy
0.75
0.50
0.25F
re
qu
en
cy
10 20 30 40 50
0.25
-0.25
0.00
10 20 30 40 50
--C-VCGK---DDDGEMLLCDGCDRWYHLYCLGPPLE--EVPEG-DWFCPECR--K-
--C-VCGK---DDDGEMLLCDGCDRWYHLYCLGPPLE--EVPEG-DWFCPECR--K-
L2
V
D1
D2
D2
D2
D2L2 D1 V
Δ
Fr
eq
ue
nc
y
PHD pfam reference
D2 perturbation D2 perturbation
A
SUPPLEMENTARY FIGURE S11
B
NATURAL SEQUENCES
ARTIFICIAL SEQUENCES
C
W
T-CLVCRK--GDNDEFLLLCDGCDRGCHIYCHRPKME--AVPEG-DWFCTVCL--AQ BAZ2A T-CLVCRK--GDNDEFLLLCDGCDRGCHIYCHRPKME--AVPEG-DWFCTVCL--AQ
PHD
10 20 30 40 50D2
1.0
|Δ
En
tr
op
y|
0.5
0.0
10 20 30 40 50D2
4
3
2
1
En
tr
op
y
0.0 0.4 0.8 0.0 0.4 0.8
L2
D1
0.0 0.4 0.8 0.0 0.4 0.8
20
40
60
V W
0.0 0.4 0.8
20
40
60
L1
0.95 0.63 0.85
0.52 0.25
0.0 0.4 0.8
C
0.99
Occurrence Frequency
Fr
eq
ue
nc
y 
(%
)
Fr
eq
ue
nc
y 
(%
)
PHD alignment position PHD alignment position
PHD alignment position
10 20 30 40 50
PHD alignment position
4
3
2
1
En
tr
op
y
10 20 30 40 50
PHD alignment position
0.25
-0.25
0.00
Δ
En
tr
op
y
EntropyNATURAL_SEQ -  EntropyARTIFICAL_SEQ
D2 perturbation
D2 perturbation
Δp (  )
Δp (  )
AP2
	
	
	
82	
frequency of the most frequent residue (right panel). The top and the middle panels respectively are for 
natural and perturbed natural sequences. As an example, the D2 position (red bar) is perturbed here and the 
perturbation is achieved by retaining only Asp at the D2 position. The bottom panel is respectively for 
changes in entropy (∆Entropy, left) and frequency (∆p, right) upon perturbation at D2 position. For 
convenience, modulus of ∆Entropy (|∆Entropy|), and positive enrichment (∆p > 0, symbol ‘­’) and 
negative enrichment (∆p < 0, symbol ‘¯’) are indicated. Green bars in the bottom panel are for positions 
showing ∆Entropy higher than that of the remaining 80% of the positions (dashed line). The aligned 
sequence of PHD (top) is represented by the most frequent amino acid at each position in the 85% non-
redundant PFAM sequences. The aligned BAZ2A PHD sequence representing the correspondence between 
positions is also shown for convenience. Empty bars are for positions where a gap is the most frequent 
symbol for an alignment column. (B) Characteristics of the artificial sequences categorized by entropy 
(left) and occurrence frequency (right). For the left panel, only one iteration of the set of 1000 sequences is 
shown. The right panel includes 100 iterations of the set of 1000 sequences. The distribution of the 
conditional probability in the 100 iterations of the set of 1000 artificial sequences is compared with the 
conditional probability (vertical arrow) of obtained from natural sequences. The vertical arrow represents 
the conditional probability of the indicated position when perturbed (e.g., the D2 position) while the 
horizontal arrows indicate the direction of the deviation of the conditional probability obtained from 
artificial sequences from that obtained from natural sequences. The direction of the horizontal arrow also 
indicates, positive enrichment (right-hand direction) and negative enrichment (left-hand direction). For 
reference, the behavior of Zn-chelating-Cys residue is included to show that highly conserved positions do 
not undergo change between natural and artificial sequences. (C) Entropy (left) and ∆Entropy (right) from 
the average of 100 iterations show that entropy of a column of aligned artificial sequences is very similar to 
that of natural sequences.  
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Figure 3.11. E-values and MI of PHD artificial sequences: (A) The –log10 (E-value) of the artificial (top) 
and natural (bottom) of PHD sequences. (B) The inter-residue MI values represented in a circular form 
along the protein sequence (created by the MISTIC web server) are shown for the artificial (top) and 
natural (bottom) sequences. The positions of interest (L2, D2, W etc.) are indicated on the BAZ2A 
sequence, while N and C respectively represent the N- and C-terminus of the protein. (C) Comparison of 
the inter-residue MI scores between artificial (top) and natural (bottom) sequences. 
 
Peptide Binding-site Hotspot Propensity  
          Using the pepx95 high-resolution peptide-protein complex structural dataset 
(described in Chakravarty et al.)7, we carried out peptide hotspot propensity calculations 
following the procedure of London et al46. Briefly, Rosetta in silico alanine scanning 
mutagenesis96 was used to estimate the energetic contribution of peptide residue in the 
selected peptide-protein complexes. Peptide residues with ΔΔG of 1 kcal/mol or more 
were considered hotspots. 270 peptide-protein complexes, where the peptide had at least 
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one Arg (in 140 complexes) or one Lys residue (in 130 complexes), were selected for 
calculations. The frequency of occurrence (Fr_e) of peptide amino acids when making 
large energetic contributions towards overall binding (ΔΔG ≥ 1 kcal/mol) and the 
frequency of occurrence peptide amino acids (Fr_b) were used to compute the reference 
hotspot propensity ratio (Fr_e/Fr_b) (Figure 3.12B, top). Peptide residue with the 
propensity ratio (Fr_e/Fr_b) >1.0 was considered to be a hotspot. Propensity of peptide 
amino acids to appear adjacent to an Arg hotspot residue (ARG-Nearness) was calculated 
similarly by diving the occurrence frequency of peptide amino acids appearing adjacent 
to hotspot Arg residue (i.e. ± 2 residue positions) by Fr_b (Figure 3.12B, bottom). 
Frequency of occurrence of Arg hotspot residues was computed considering a 5-residue 
stretch spanning ± 2 residue positions on either side of the Arg hotspot residue (Figure 
3.12A). Eighty five percent of peptide Arg hotspot residues were observed to be at the 
center of sequence segments spanning five residues (Figure 3.12A), while for the 
remaining 15%, the Arg residue is either close to the peptide terminus (e.g., H3R2 in 
PHD recognition) or is within a motif consisting of less than five residues (e.g., the 
WDR5-interacting [Win] –AR– peptide motif)97. 
          Propensity of protein binding site hotspot residues making non-polar contact with 
peptide residues present at ± 2 residues of the peptide hotspot residue (see Figure 3.12C, 
right cartoon) was computed in the following way. LIGPLOT98 was used to determine 
protein binding-site residues in contact with the peptide ligand. Non-polar carbon atom 
contacts were taken from LIGPLOT’s ligand-protein contact list. The frequency of 
occurrence (Fr_np) of protein amino acids having non-polar contacts with peptide 
residues present at ± 2 residues of peptide hotspot residues (Figure 3.12C, right cartoon) 
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that make large energetic contributions (ΔΔG ≥ 1 kcal/mol) was computed. The 
frequency of occurrence of protein binding-site amino acids (Fr_pb) was used to compute 
the propensity ratio (Fr_np/Fr_pb) (Figure 3.12C). A binding-site residue is one that has 
∆ASASC > 0.0 Å2 (see below). A protein Arg residue side chain atom can also have non-
polar contacts using its −(CH2)3− group, and therefore, polar residues can also be present 
in Figure 3.12C. 
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Figure 3.12. Recognition characteristics of Arg-rich peptides: (A) The frequency of occurrence of peptide 
Arg (R) hotspot (rossetta DDG > 1.0) residues in peptides. Fifteen percent of times, the Arg-hotspot residue 
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appears close to the peptide terminal or within motifs smaller than five residues, while the remaining 85% 
of times it appears at the center of the sequences spanning five residues. (B) The propensity of peptide 
hotspot residues (top) and the propensity of residues to appear adjacent to Arg hotspot residue (± 2 
residues) (bottom). (C) The propensity of protein hotspot residues (left) making non-polar contacts with 
peptide residues adjacent to the peptide Arg hotspot residue (right cartoon). (D) Examples of proteins 
(gray) recognizing histone/histone-like Arg-rich peptides (green) where peptide residues with small side 
chains (Gly, Ala and Thr) are in contact with bulky nonpolar (light pink) protein residues. Mesh surface 
represents the peptide residues with small side chain. Protein name, residue name and the pdb ids are 
indicated. 
 
Packing Density, Surface Area and Secondary Structure  
          We used the Voronoia program99 to compute packing density of atoms. Voronoia 
program reports packing density (PD) of an atom as the ratio, PD = VvdW/(VvdW+ 
Vse), where VvdW is the volume inside the van der Waals sphere of an atom, and Vse is 
the remaining solvent excluded volume assigned to each atom99. For PD of a set of 
atoms, we average the PDs of the set of atoms of interest. Only high-resolution structures 
(resolution ≤ 2.0Å) were considered for packing calculations. The packing density of 
atoms varies depending on their distance from the surface100. Therefore, atom depth101 
was computed for packing analysis. Atom depth was computed here as the distance from 
the nearest surface atom (atoms with non-zero surface area). Reference distribution of 
packing density as a function of atom depth  (see Figure 3.13) was calculated using the 
PISCES102 non-redundant set (≤ 26% sequence identity and resolution ≤ 1.6 Å) of 3700 
pdb single chains with size ≥ 50 residues. For discussion of the energetic contribution 
residues in the context of PHD scaffold structures, a set of 15 high-resolution (≤ 2.0 Å) 
PHD–peptide complexes belonging to different subtypes (Figure 3.2A) and having a low 
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sequence similarity with one another (sequence identity ≤ 40%) were chosen. We refer to 
the structures of this set for the packing density (PD) discussion of L1, L2 and V 
positions. As peptide–protein interfaces have been observed to be very tightly packed, 
even more tightly packed than protein–protein interfaces46, we rationalized the 
contributions of nonpolar residues at L1 and L2 with respect to interfacial packing. 
Having observed the disruptive consequences of substitution of the tightly packed H3A1 
residue, the –CH3 group in several PHD–peptide complexes in an earlier study7 
encouraged us to look in a similar manner at interfacial nonpolar group packing in 
BAZ2A proteins. 
          NACCESS103 program was used to compute the accessible surface area (ASA). 
The amount of surface area lost by the side chain atoms of a protein residue upon 
formation of a peptide–protein complex is measured by ΔASASC. ΔASASC of the ith 
residue is, ΔASASC_res_i = (residue_i_ASASC_protein) – (residue_i_ASASC_complex) 
where residue_i_ASASC_protein and residue_i_ASASC_complex are respectively the side 
chain atom surface area of the ith residue in the free and bound form of the protein. 
Protein residues with ΔASASC ≥ 10Å2 are considered to make contact with the peptide 
(Figure 2.14A). ΔASASC of protein hotspot residues (Figure 3.14) is also computed this 
way. Assignment of the secondary structural elements (SSE) of coordinate files was 
carried out using the SEC-STR program104, and the SSE symbol ‘G’ was taken as the 310-
helix. Amino acid frequencies of segments with 310-helix conformation were used to 
check the preference of Asp residues within the 310-helical segments of the PISCES102 
non-redundant set.   
	
	
	
89	
 
Figure 3.13. Reference packing density of nonpolar atoms: The reference packing density distribution of 
specific type of atoms as a function of their distance from the surface. These distributions were used here 
(e.g., Figure 3.17 and 3.19). 
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Figure 3.14. Characteristics of DASASC of protein hotspot residues: The distribution of the ∆ASASC of 
Leu/Ile/Met (left, top) and Phe (top, right) of protein hotspot residues upon peptide binding. The dashed 
lines indicate the DASASC of L1 and L2 residues in PHD_nW_DD subtype. Above are examples where L1 
like DASASC of peptide complexes are noted. Mesh surface represents the peptide and protein hotspot 
residues in contact with each other. Protein name, residue name and the pdb ids are indicated. 
 
Peptide Swapping and Peptide Backbone Clash 
          Using the MUSTANG85 structural alignment (Figure 3.2A), the coordinates of one 
PHD–peptide complexes were superposed and then transformed onto another. For 
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the peptide coordinates of one complex are then placed onto another. For example, the 
peptide coordinates of the transformed NSD3-PHD complex are placed onto transformed 
coordinates of KAT6A-PHD2.  We refer to this as peptide swapping. This is a simple but 
a crude approach, as it does not optimize backbone hydrogen bonding. The extended 
conformations of peptides in the PHD_nW subtype (2puy, 4gne, 4qbs and 3qla) were 
placed onto the PHD_nW_DD subtype (4q6f, 3asl, 5b75 and 5i3l). PHD–peptide inter-
molecular backbone carbon–carbon contact distances for H3 residues 4-7 were 
determined using LIGPLOT98 (Figure 3.21D). As a positive control, peptides in the 
PHD_nW subtype (2puy, 4gne, 4qbs and 3qla) were swapped among themselves for a 
rough estimate of the error (~16%) contributed by the crude swapping approach 
 (Figure 3.21C). As PHD sequences of these complexes share < 40% sequence identity, 
comparison of results obtained by swapping between subtypes (e.g., PHD_nW and 
PHD_nW_DD) and those within a subtype (e.g., PHD_nW) was acceptable. 
 
RESULTS AND DISCUSSIONS 
Binding energetics of the BAZ2A PHD finger in the context of the PHD superfamily 
          Though diverse sequences populate this family, PHD finger sequences can be 
grouped into two major functional subtypes7: (i) the PHD_W subtype and (ii) the 
PHD_nW subtype (Figure 3.7). The justification for this grouping is that functionally 
related positions show enrichment in specific residue types among the subtype sequences; 
e.g., aromatic cage-forming positions are enriched with aromatic residues in the PHD_W 
subtype7. Positions in the PHD finger superfamily corresponding to the BAZ2A PHD 
were similarly checked for residue-type enrichment. The overall result for the occurrence 
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frequency and residue enrichment at the L1 and L2 positions of the PHD superfamily is 
represented as sequence logos in Figure 3.15. It is clear that bulky nonpolar residues (Ile, 
Val, and Leu) are always present at the L1 position irrespective of the subtype; i.e., p = 
0.95 is observed for the entire superfamily (Figure 3.15A, B). However, this is not the 
case for the L2 position, as the occurrence frequency of bulky nonpolar residues is 
progressively enriched (0.32 → 0.51 → 0.82) as one moves from the superfamily level to 
specific subtypes (Figure 3.15B). Interestingly, the value of p for the bulky nonpolar 
residues at the L2 position in PHD_W subtype sequences is negligibly small (p = 0.05). 
The PHD treble clef knuckle xCDxCDx sequence pattern mentioned above refers to the 
PHD_nW_DD subtype, which includes the BAZ2A PHD, KDM5B PHD, UHRF1 PHD, 
KAT6A DPF, and DPF3 DPF domains. A bulky nonpolar residue at L2 seems to be a key 
feature of the PHD_nW_DD subtype. As a control, we also checked the xCDxCDx 
motif-containing sequences (e.g., TAF3 PHD, DIDO PHD) in the PHD_W subtype, and 
we observed that they never include bulky nonpolar residues (p = 0.03) at L2  
(Figure 3.15B), suggesting that PHD_nW_DD is likely to be a distinct subtype. In other 
words, in addition to having the pair of Asp residues in a treble clef knuckle, the 
PHD_nW_DD subtype likely has additional features, such as a bulky nonpolar residue at 
L2. To confirm the energetic contribution of residues at L2 for the PHD_nW_DD 
subtype, we also mutated bulky nonpolar residues to Ala at the L2 position in hUHRF1 
PHD (M345A), hKDM5B PHD (L326A), and hKAT6A DPF (F280A) domains (Figure 
3.16A and see Figure 3.2 alignment). The L2 position mutants of the hUHRF1 PHD, 
hKDM5B PHD, and hKAT6A DPF did not show any detectable peptide binding 
according to ITC (Figure 3.16A), suggesting that substitution of the bulky nonpolar 
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residues completely disrupted peptide binding. This suggests the importance of the 
energetic contributions of bulky nonpolar residues at the L2 position in the 
PHD_nW_DD subtype. The sequence identity distribution within subtypes (Figure 3.7B) 
suggests that, although the median value increases from the superfamily level to the 
PHD_nW_DD subtype, there are diverse sequences in the PHD_nW_DD subtype. For 
example, the hBAZ2A PHD, hUHRF1 PHD, and hKAT6A PHD2 share less than 40% 
sequence identity with each other. Yet these members retain similar peptide-anchoring 
residues, indicating a similar binding mechanism and therefore providing a reason to 
select them for the subtype study. 
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Figure 3.15. PHD subtypes, and L1 and L2 enrichment: (A) PHD topology cartoon (left) showing the 
strand that augments the peptide (green) harboring the L1 and L2 positions. Sequence logo (right) showing 
strand-knuckle-strand segment of the PHD fold with the secondary structural elements on top. The 
occurrence frequency of bulky nonpolar residues at L1 and L2 positions is below the logo. (B) Sequence 
logo of the two major PHD subtypes, PHD_W (left) and PHD_nW (right). Structures of representative 
members of these subtypes are adjacent to the logo showing the characteristic key residues in stick (light 
pink). The lower panel (shown with arrow) indicates logo of sequences extracted from the two respective 
subtypes with the knuckle having xCDxCDx sequence pattern. The occurrence frequency of bulky 
nonpolar residues at L1 and L2 positions is similarly below the respective logos. The pdb ids are in 
brackets, and convenience H3C4 atom in TAF3 PHD is represented as N (blue). 
 
Justifying the contribution of the L1 position 
          For the BAZ2A complex, the L1692 Leu CD1 atom is in van der Waals contact 
with the H3A1 residue –CH3. The packing density of the BAZ2A L1692 Leu CD1 atom 
in the BAZ2A complex is observed to be higher than what is typically observed for the 
Leu CD1 atom at similar distances from the protein surface (Figure 3.16B), justifying the 
role of the L1692 side chain in tightly anchoring the H3A1 residue –CH3. The packing 
density of the BAZ2A L1692 Leu side chain atoms in the complex is 0.62. Irrespective of 
the PHD subtype, L1 residues (p = 0.95) in the 15 PHD–peptide complexes are also in 
van der Waals contact with the H3A1 –CH3 functional group. The average side chain 
packing density (0.623 ± 0.032) of nonpolar L1 residues in these complexes suggests that 
the L1 residues are packed very similarly as in the BAZ2A complex (Figure 3.16C). The 
similarity between H3A1–CH3 anchorage by BAZ2A L1692 and by the L1 residue in the 
rest of the complexes can further be appreciated by noting that ΔASASC for the L1 
residue in 15 complexes (17.15 ± 4.4 Å2) is close to that of BAZ2A L1692 (~15 Å2). In 
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other words, despite low sequence identity, diverse members of the PHD superfamily 
utilize the L1 nonpolar residue in nearly identical fashion in anchoring H3A1–CH3, and 
its substitution thus likely leads to a poorly packed interface, resulting in the disruption of 
the complex. The replacement of L1 nonpolar residues to Ala in the BAZ2A, UHRF1, 
KAT6A, and KDM5B (Figure 3.16A) PHD fingers therefore severely compromises 
peptide binding. In the recently acquired structures of the zf-CW domains105, 106 (e.g., 
MORC3, ZCPWP2, and ZCPWP1) in complex with the histone H3K4me3 peptide, one 
also observes that H3A1–CH3 (Figure 3.2C) is in van der Waals contact with a highly 
conserved nonpolar residue (p = 0.80) in the zf-CW scaffold, located at a position 
corresponding to that of the PHD L1 position (Figure 3.2B–D). As both PHD and zf-CW 
domains require the peptide NH2-terminal for backbone-mediated hydrogen bonding, it is 
interesting to note that both have adopted very similar mechanisms for anchoring the 
terminal Ala –CH3 group by utilizing a nonpolar L1 residue (Figure 3.2B–D). These 
observations are also important in the context of histone reader reengineering. 
Reengineering the PHD and zf-CW domains for effectively reading marks other than at 
the H3-terminal would most likely require manipulation of the L1 position. 
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Figure 3.16. PHD_nW_DD subtype mutations: (A) ITC titration profiles of wild type and mutants of 
hKDM5B PHD (left), hUHRF1 PHD (middle) and hKAT6A DPF (right) with histone H3 peptide. (B) DGo 
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of the forward binding reaction is shown (as -DGo) for the three readers, hKDM5B PHD (top), hUHRF1 
PHD (middle) and hKAT6A DPF (bottom). For convenience of comparison, BAZ2A mutants are shown at 
the bottom. Residues that contribute more than 1 kcal/mole of free energy are below the dotted line. Red 
bars are for positions where binding was not detected in ITC experiments. (C) Distribution of packing 
density of Leu-CD1 atom (top) in proteins within the shell of 3.5 – 5.5Å from the protein surface, and the 
packing density of BAZ2A L1692 CD1 (red dashed line) within similar distances from the surface in the 
BAZ2A complex. Surface mesh (bottom) representing the contact between H3A1-CH3 and L1 position in 
BAZ2A. (D) Surface mesh representing the contact between H3A1-CH3 and L1 position in different 
subtypes. In the mesh representations, protein carbon atoms are in light pink and peptide carbon atoms are 
in split pea color. 
 
Justifying the contribution of the L2 position  
          In a similar manner, we then looked at the BAZ2A PHD L1693 residue. The CD1 
and CG atoms of this residue (L2) are in van der Waals contact with the histone H3 Thr3 
backbone C atom (Figure 3.18B). Moreover, the packing density of the CD1 and CG 
atoms of this residue in the BAZ2A complex is similarly found to be higher than 
typically observed for other Leu CD1 and CG atoms at their respective distances from the 
surface (Figure 3.18A), and their contacts with the peptide backbone C atom maintain a 
well-packed environment for the PHD–peptide complex. The structural changes for the 
BAZ2A L2 position upon peptide binding are, however, different from those at the L1 
position. The ΔASASC values for the L1 and L2 positions are ~20 Å2 and ~55 Å2, 
respectively, for BAZ2A (Figure 3.14). A value of 20 Å2 for ΔASASC of a hotspot 
residue is, however, far less common (ASA ≅ 20 Å2, Figure 3.14). A more common 
scenario for protein hotspot residues is the one observed for the L2 position, where the 
residue is nearly fully exposed and then undergoes a large change in surface area while 
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contributing to tight interfacial packing. The change in packing density (ΔPD) of the 
BAZ2A L2 side chain atoms is 0.16, while that of those at the L1 position is 0.08. Similar 
to the BAZ2A L1693 residue, bulky nonpolar residues at the L2 position in UHRF1 
(M345), KAT6A (F280), and DPF3 (F333) complexes pack against peptide backbone 
carbon atoms (Figures 3.17A, 3.18B). In general, in the PHD_nW_DD subtype, L2 
residue side chain atoms contribute toward tightly packing the peptide backbone atoms. 
This is in contrast to the contacts made by L2 residues in other subtypes. In the PHD_W 
subtype, L2 residues, with smaller side chains (e.g., Gly, see Figure 3.2A), are typically 
not in contact with H3 peptide backbone atoms (Figure 3.18C). Based on the side chain 
size, the PHD_nW subtype members may or may not retain contacts with the peptide 
backbone (Figure 3.17B). The side chain packing density of L2 residues in the three 
subtypes, 0.520 ± 0.045 (PHD_W), 0.542 ± 0.029 (PHD_nW), and 0.572 ± 0.038 
(PHD_nW_DD), also shows a trend of enhancing packing for residues at L2 in the 
PHD_nW_DD subtype. In short, backbone contacts by the L2 residue are likely to 
contribute in a subtype-specific manner.  
          Why should there be a need for a contribution from the L2 residue in a subtype-
specific manner? We will try to rationalize the answer for this in the following. 
Anchorage of the peptide side chain H3Lys4 quaternary ammonium ion  
(–CH2N+(CH3)3) by the PHD aromatic cage and the terminal H3A1–CH3 by the PHD L1 
likely dominate the peptide-binding energetics in the PHD_W subtype (Figure 3.17C). 
Salt bridge-mediated H3Lys4 and H3Arg2 anchorage and H3A1–CH3 anchorages by L1 
likely dominate the binding energetics in the PHD_nW subtype (Figure 3.17C). For the 
PHD_nW_DD subtype, we had earlier discovered that peptide binding might not require 
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an energetic contribution from the H3Lys4 residue7. The lack of energetic contribution 
from the H3Lys4 residue must be compensated by additional contacts, such as those 
made with bulky L2 residues. Thus, the L2 contribution is likely to be an essential feature 
for peptide binding in the PHD_nW_DD subtype, as we showed that substitutions of 
bulky L2 residues with Ala in the BAZ2A, KDM5B, UHRF1, and KAT6A proteins 
(Figure 3.16A) completely disrupt peptide binding for all of them. Other subtypes may 
not require L2 contacts (p ≅ 0.05), as they have other strong, specific, peptide-anchoring 
contacts and thus can afford to have residues with smaller side chains (e.g., Gly) at the L2 
position. Inspecting the alignments and structures of the PHD_nW subtype, one observes 
that the DNMT3A ATRX–DNMT3–DNMT3L (ADD) domain retains the bulky nonpolar 
L2 residue, but the ATRX and AIRE proteins do not (Figures 3.2A, 3.17D). It is 
interesting to note that the treble clef knuckle Asp residue forming a salt bridge with 
H3R2 is absent in the DNMT3A ADD domain but is present in the ATRX and AIRE 
proteins (Figure 3.2A, 3.17B). For AIRE, substitution at the L2 position (C310L) by 
introduction of a Leu residue enhances affinity for the unmodified H3 peptide by ~15 
fold (Figure 3.18D). A gain in free energy (ΔΔG) of ~1.5 kcal/mol could compensate for 
the loss of another interaction of similar strength. It is thus temping to speculate that the 
loss of one type of contact is likely to be compensated by another, such as the L2 contact. 
However, these speculations will need to be confirmed by detailed experimentation as 
part of a further investigation.  
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Figure 3.17. L2 contacts in other subtypes: L2 contacts in DPFs (A) and PHD-nW (B). (C) Anchor points 
in in different subtypes are represented by double headed arrow. (D) A symbolic representation of 
	
	
	
101	
adjustments due to position specific residue substitution. A red ‘capsule’ represents absence while the 
arrow (dashed line) indicates presence of a specific residue at the same site.  
 
 
Figure 3.18. L2 mutations in PHD_nW_DD subtype: (A) Packing density of BAZ2A L1693 CD1 (top) and 
CG (bottom) are shown as red dashed lines among the distributions of Leu CD1 and CG atoms respectively 
within the indicated shells in protein structures. (B) Surface mesh representing the contact between BAZ2A 
L1693 side-chain and the peptide backbone (top) and similar L2 contacts for UHRF1 (bottom). (C) Mesh 
surface representations of the L2 contacts in PHD_W subtype for comparison. (D) ITC titration profiles of 
the wild type and L2 (C310L) mutant of AIRE PHD with histone H3-1-11 peptide. Mesh coloring is same 
as that in Figure 3.16. 
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Other nonpolar residue contributions at the interface of BAZ2A and the Subtype 
          Substitution of V1713 to Ala in BAZ2A (Figure 2.14, Table 2.8) also weakens 
peptide binding (ΔΔG = 1.1 kcal/mole). BAZ2A V1713 is in contact with histone 
H3Thr3–CH3 (the CG1 atom) and thus contributes to packing with the Thr3–CH3 group 
(Figure 3.19B, C). We similarly observed the enrichment for nonpolar residues at a 
position corresponding to BAZ2A V1713 (Figure 3.19B); e.g., the occurrence frequency 
is enhanced (0.38  0.64) in the PHD_nW_DD subtype (Figure 3.19B). However, the 
packing density of the V1713 side chain atom (Figure 3.19C) in contact with the peptide 
is lower than that observed for the L1 and L2 atoms. This is also consistent with the 
observation that the energetic contributions of L1 and L2 towards peptide binding are 
greater than that of V1713, suggesting that the tighter the packing, the larger the energetic 
contribution to be expected. Interestingly, the enrichment at this position is smaller than 
at the L2 position (0.320.81) and is also consistent with its respective energetic 
contribution. For the PHD_nW_DD subtype, however, it is interesting to note that, 
despite low sequence identity, BAZ2A, UHRF1, and KAT6A PHD2 have near-identical 
structures in this region (Figure 3.19B). Thus, the observed occurrence frequency of 
nonpolar residues in a position corresponding to that of BAZ2A V1713 in this subtype is 
more reliable than that of the PHD_W subtype, which includes insertions/deletions in this 
region (Figure 3.19B). We therefore believe that it is a subtype-specific adaptation to 
strengthen the anchorage of H3T3–CH3, as UHRF1 V365 and KAT6A M300 are also in 
van der Waals contact with H3T3–CH3, like BAZ2A V1713 (Figure 3.19D). This is also 
consistent with an earlier observation that substitution of H3Thr3 to Ala severely 
compromises peptide binding in BAZ2A and KDM5B7. With respect to PHD reader 
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contact with the peptide, the contribution of H3Thr3CH3 (CG1 atom) is anticipated to 
be different from that of the OH group (OG1 atom) for the observed effects of the H3 
(ThrAla) 3 substitution. This is further substantiated by the recently obtained DPF 
structures of KAT6A24, 81 and DPF3106, in which H3Thr3–OH is engaged as the N-cap107 
for the peptide helix, while H3Thr3–CH3 is oriented towards the enriched nonpolar 
residue side chain (Figure 3.19D). Thus, enrichment of multiple nonpolar residues 
(including Pro, L2) at specific positions is observed in the PHD_nW_DD subtype, which 
shows a strong preference for contacts with the H3Thr3 backbone (L2) and side chain 
atoms. As discussed above, a gain in specific contacts is likely to be a compensatory 
adjustment for the loss of another contact, and the PHD_nW_DD subtype is enriched 
with residues for making contact with the first three H3 residues (H3A1-T3) at the 
expense of other contacts. Tracing the orthologs of human PHD fingers, it had earlier 
been noted that KDM5B PHD and UHRF1 (of the PHD_nW_DD subtype) are likely 
among the early “inventions” of the PHD7. Among the orthologs of the KDM5B PHD, 
tracking the positions that show a gain in specific contacts with the peptide suggest that 
anchoring histone H3 by the first three residues (H3A1-T3) could have been an early 
adaptation by utilizing position-specific nonpolar residues (Figure 3.20A). The DPFs, in 
addition to these features, also extended their contacts with H3 well beyond the H3-1–3 
residues by utilizing the non-canonical surface of the PHD1 of the DPFs24, 81, 106, 108, 109.  
Enrichment of multiple nonpolar residues among histone readers was also observed 
earlier; e.g., the histone H3K9me3 and H3K27me3 readout by the chromodomains of 
human CBX paralogues110. CBX2, -4, -6, -7, and -8 retain a pair of position-specific 
clasping nonpolar residues at the peptide binding site (Figure 3.20C) in place of a pair of 
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clasping negatively charged residues in the corresponding positions in CBX1, -3, and -
5110. Cbx1, -3, and -5 bind peptides with a higher affinity and are more specific for 
H3K9me3. By contrast, CBX2, -4, -6, -7, and -8 bind peptides with lower affinity and 
poorly discriminate between H3K9me3 and H3K27me3110. Thus, the nonpolar residues in 
the CBX example contribute to lowering affinity and specificity. The packing density of 
the CBX2 binding-site nonpolar residue (V11 and L50) side chain atoms in complex with 
the H3K27me3 groups (Figure 3.20C) are only 0.39 and 0.43, respectively, which are 
much lower than at the L1, L2, and V positions of PHD_nW_DD. The enriched nonpolar 
residues observed here certainly contribute to strengthening specific interactions due to 
tight packing and thus are distinct in behavior from those of the CBX example.  
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Figure 3.19. Enrichment at other positions: (A) The sequence logo (right) of the segment of interest 
(dashed line in the topology cartoon, left). (B) Sequence logo of the same segment respectively of PHD_W 
(top, left), PHD_nW (top, right) and PHD_nW_DD (bottom, right) subtypes. Structures of the segment of 
interest in PHD_nW_DD subtype (bottom, right). Occurrence frequency at the positions of interest is below 
the logo, and the pdb ids of the proteins are in Figure 3.2. Side-chains of position in BAZ2A that are 
enriched in this segment are highlighted with sticks (light-pink) in the structures (bottom, right). Structures 
of the segment of interest in PHD_W subtype structures (bottom, left). The segment of interest indicated in 
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(A) is similarly indicated with a circular dashed line. (C) Packing density of BAZ2A Val-CG2 atom is 
compared with that of Val-CG2 atom (reference) within similar distances from protein surface. (D) 
Orientations of H3Thr3-CG2 and H3Thr3-OG1 atoms in UHRF1 (left) and KAT6A (right). Light pink and 
green curved lines represent non-polar contacts. ‘N-cap’ hydrogen bonded capping of helix N-terminus.  
 
 
 
Figure 3.20. KDM5B orthologous sequences and other nonpolar contacts: (A) Tracing BAZ2A residues 
(light pink) in contact with H3 peptide among the KDM5B orthologs. (B) Residue contacts of histone 
H3Thr3-CH3 in the PHD_W subtypes. The PHD_W subtype may or may not retain contacts with H3Thr3-
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D0NGM0_PHYIT AYNSEICQVCLRGDCWDR-MLLCD--GCNSGQHIFCLDEPLDKVP-TGDWYCKECVD
C1E8J6_MICSR EEQPAGCVNCGGTSHEES-MILCD--GCDRGYHMYCLSPPLDELP-QGDWFCPDCIA
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F9XHU9_MYCGM FRPGEMCETCGKGDDPHR-LLKCE--SCDNVYHMGCLDPPRTHAP-EHEWHCPRCLV
G1X2E1_ARTOA TKPGEKCEKCGRGDDATS-LLLCD--GCDHGYHTYCLDPPVKTIP-ERDWYCNRCLV
G2Y6N5_BOTF4 LDSDQKCETCGKGDDADK-ILICE--SCDYGHHMQCLDPPVTHKP-DFDWHCPRCLV
G4N2P7_MAGO7 TPSPEKCHLCARGKETGF-IVVCE--SCDYGYHGMCLDPPLKTKP-DTEWNCPRCLV
G4TCL3_PIRID EAHGDYCEICKASEKPSE-MLLCD--GCDGGFHIFCLDPRLPTVP-KGQWFCHSCLD
H6BSH0_EXODN RRQGEKCEKCGKSDNKES-ILICD--TCDMGYHKHCIDPPLRQMP-DYDWHCSKCLV
J3K915_COCIM RKTGDKCETCGKSNDRPS-ILLCD--GCDNGYHMHCLDPPLSNAP-NYDWHCPKCLV
J3NXR1_GAGT3 TPATEKCNACGNAISAAL-CVICD--SCDLRYHGSCINPPLKATP-ETEWNCPRCLV
J5JFP5_BEAB2 LTPHETCETCGQGEDAGP-LLVCE--SCDNSYHGLCLDPPVKRKP-DAEWNCPRCLV
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Q5KHN4_CRYNJ YQKGEVCEICKGEHDADK-ILLCD--GCDRGFHIYCLDPPLASVPTNEEWYCTSCLL
C0NTM6_AJECG RKTGERCENCGKSDNRPT-ILSCD--GCENGYHIHCLDPPLDSVP-DFDWHCPKCLV
D5GP65_TUBMM SKPGEKCEKCGRGDDMAN-LLLCE--SCDHGYHTFCLEPVLKSVP-DRDWYCDRCLV
K1W8D6_MARBU SAPGEKCENCGKNDDLGN-LLVCD--SCDLGYHMHCLDPQVAQKP-DYDWNCPRCLV
K9FMU8_PEND2 QPAGEKCETCGKSDDQGS-ILVCD--GCELGYHKACLDPSTTTPT-EHDWHCPKCLV
B8MDD0_TALSN RKTGEKCEACGKTDNPET-IFVCD--SCENGYHKSCLENPLNADP-DYDWHCPKCLV
J4UA76_TRIAS KLTLKVCEICSLGNNAPK-ILLCD--GCDRGFHTFCLDPPLQDIP--DEWYCTACLL
K5X9M0_AGABU GTSEQSCEICHKANRGDK-MLLCD--ECDCGFHMDCLDPPIATIP-ADNWFCN-CLS
G0SY23_RHOG2 RRPGEACEICTLDHDPDR-IVLCD--ECDRGYHLHCLTPPLKQVP-TSQY-CDKCLL
A8Q274_MALGO QERTTACSDCSVCKGHAKPIVTCA--ECEQSYHLKCVTPPLSQVP-RGDWICPTCLV
I4YA45_WALSC NGSSIECSNCKQFDTPDR-VVQCA--ECENHFHLDCLIYPLLKRPDVQDWFCDACLY
KDM5_DROME   PLMKYICHICNRGDVEES-MLLCD--GCDDSYHTFCLLPPLTSIP-KGEWLCPRCVV
A8PQK2_BRUMA PMDEVVCRKCEKGDDEDY-LLLCE--DCDYALHTYCCSPALSNVP-RSEWRCRRCLL
B4MUZ4_DROWI PLMKYICHICNRGDIEEA-MLLCD--GCDDSYHTFCLLPPLSSIP-KGEW-CPRCVV
KDM5_CAEEL   PMDQVFCVACNEGKDEDL-LLLCDIDGCNNGRHTYCCDPVLDEVP-EGEWRCPKCES
H2VI17_CAEJA PMDQVYCIACHQGKDEDL-LLLCDISGCNNGRHTYCCDPVLDE-P-EGEWRCPKCIE
KD5BB_DANRE  -VDLYVCLVCGKGNDEDR-LLLCD--GCDDSYHTFCLIPPLTDVP-KGDWRCPKCLT
KDM5B_MOUSE  AVDLYVCLLCGSGNDEDR-LLLCD--GCDDSYHTFCLVPPLHDVP-KGDWRCPKCLA
BAZ2A_HUMAN  SVNKVTCLVCRKGDNDEF-LLLCD--GCDRGCHIYCHRPKMEAVP-EGDWFCTVCLA
KDM5B_HUMAN  AVDLYVCLLCGSGNDEDR-LLLCD--GCDDSYHTFCLVPPLHDVP-KGDWRCPKCLA
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CH3. (C) The pair of clasping residues of human CBX chromodomain proteins at the histone peptide-
binding site. 
 
Contributions of negatively charged residues at the interface of the Subtype 
          As the PHD_nW_DD subtype is characterized by the presence of a pair of Asp 
residues (in the xCDxCDx motif), we wanted to understand the contributions of the 
BAZ2A D1695 (D1 position) and D1698 (D2 position) residues in the context of subtype 
structure. The substitution of D1695 severely compromises binding, consistent with the 
observed effects of D1 substitution in the UHRF119, KAT6A81, and KDM5B7 proteins. 
The side chain carboxylate at D1 is engaged in a salt bridge-mediated interaction with the 
H3Arg2 residue. The complete loss of binding upon D1695 substitution is expected, due 
to the loss of the electrostatic interactions between D1695 and H3Arg2, and thus D1695 
has a very large energetic contribution, similar to that of the D1 positions in UHRF1, 
KAT6A, and KDM5B. ΔΔG for BAZ2A D1698 (D2 position) is 0.67 kcal/mole (Figure 
2.14B). ΔΔG for substitution of Asp residues at the D2 position in UHRF1 and KDM5B 
are 1.61 and 1.23 kcal/mole, respectively (Figure 3.16A, B). For KAT6A, we expect the 
energetic contribution of D2 to be as large as we observed for complete disruption of 
binding upon D2 substitution. In short, the D2 position also has a substantial contribution 
(ΔΔG >> 1.0 kcal/mole) in anchoring the H3R2 residue for the PHD_nW_DD subtype. 
This also justifies PHD finger sequence grouping by the treble clef knuckle xCDxCDx 
pattern for subtype-specific analysis, in which the Asp residues are expected to serve as 
binding hot spots. For the BAZ2A PHD, however, the contribution of D1698 (D2 
position, 0.67 kcal/mole) is less than that of the D2 position in other members as 
mentioned in chapter 2. A structural deviation of the treble clef knuckle xCDxCDx 
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pattern in the BAZ2A PHD is observed (Figure 2.16). In comparison with what is 
typically observed in other PHD fingers, the structural deviation of the knuckle places 
BAZ2A D1698 farther away from the H3Arg2 residue. This structural deviation is also 
reflected in the loss of surface area upon complex formation. The ΔASASC of BAZ2A 
D1698 is 0.0 Å2 (no H3R2 contact), while that for the D2 positions in the UHRF1, 
KAT6A, and DPF3 complexes is 17.14 ± 2.55 Å2. The smaller contribution of D1698 is 
likely due to the smaller contact (enlarged inter-residue distance) in the BAZ2A complex. 
The D1 ΔASASC (in BAZ2A, UHRF1, KAT6A, and DPF3) is 34.90 ± 3.93 Å2, while 
that of D2 is 17.14 ± 2.55 Å2. The amount of contact between the oppositely charged 
groups is also consistent with the larger energetic contribution of the D1 position to 
peptide recognition in the PHD_nW_DD subtype. 
          We then focused on the contributions of the acidic patch38 residues of BAZ2A. 
However, substitution of acidic patch residues to Ala (D1688A, E1689A) did not indicate 
whether they might contribute to the energetics of peptide binding. We actually observed 
a slightly more negative ΔG of binding for these mutants (Table 2.8A). We therefore 
focused on the structural contributions of the acidic patch, consistent with the recent 
structural report on the BAZ2A PHD (pdb code 5t8r)38. For the available PHD_nW_DD 
subtype structures, the conformation of the acidic patch segment is observed to be a 310-
helix (or consecutive turns, Figure 3.21B). Early conformational analysis111 showed that 
the occurrence frequency of Asp residues within the first three positions of the 310-helix 
or turns are higher than for other amino acids (Figure 3.21B, bottom). The enrichment of 
negatively charged residues at the acidic patch for the PHD_nW_DD subtype thus 
suggests that the sequences of this subtype likely retain a 310-helical conformation. The 
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sequences of other subtypes prefer Gly for the corresponding segment, and the 
conformation of this segment in other subtypes is distinctly different from a 310-helix 
(Figure 3.21C). These observations therefore suggest a structural, rather than an 
energetic, role for the acidic patch residues. The adoption of the 310-helical conformation 
by the acidic patch has a consequent impact on the cognate peptide conformation (Figure 
3.21C). The peptide, in the PHD_W and PHD_nW subtypes, is typically accommodated 
by β augmentation. However, the strand conformation, beyond residue number 4 of H3, 
will likely “clash” with the 310-helical conformation of the acidic patch (Figure 3.21D). 
Therefore, it is tempting to believe that the H3 peptide adopts a helical conformation in 
order to evade clashes with the acidic patch. Histone H3 thus adopts a context-dependent 
conformation consistent with earlier structural observations (Figure 3.9), and a few 
sequence features of H3 likely contribute to adopting a helical conformation. They are: 
(a) the N-cap H3T3-OH107, (b) H3G11, a helix-terminating Gly112, and (c) the K9 
positive charge for accommodating the helix dipole113 (Figure 3.21D). As we observed 
the N-cap role of H3T3-OH with other H3 readers (Figure 3.9), the H3T3ph mark in 
these readers would impede H3 helix initiation. These readers would thus not be suitable 
candidates for redesigning as H3T3ph readers. Overall, we observed distinct roles of the 
pairs of acidic residues for the PHD_nW_DD subtype as: (a) treble clef knuckle acidic 
residues anchoring H3R2 and (b) acidic patch residues influencing H3 conformation.   
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Figure 3.21. BAZ2A PHD treble clef knuckle Asp pair: (A) Structural deviation and distances between 
oppositely charged atoms among the PHD_nW_DD subtype structures (left), and the treble clef knuckle 
Asp residues pair in UHRF1 (top, right) and KAT6A (bottom, right) anchoring histone H3-Arg2 residue. 
(B) The 310-helical conformation of PHD_nW_DD subtype (top), and the similarity between 310-helical 
segments of unrelated proteins having negatively charged residues (bottom). (C) Conformation of the 
corresponding segment in PHD_nW subtype (left) with negligible intermolecular backbone atom clashes 
(black bar, below) with the strand conformation of the H3 peptide. A much larger proportion of clashes 
(black bar, below) expected for PHD_nW_DD (right) when interacting with the strand conformation of H3. 
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(D) Symbolic representation of the context dependent folding of H3 peptide upon interaction with 
PHD_nW_DD (top), and the helix punctuating features of N-terminal H3 (bottom).   
 
Mutual information between residues at the BAZ2A interface and Subtype 
          The observed enrichment of nonpolar residues around the peptide-binding site 
encouraged us to further probe the relationship between the treble clef knuckle Asp pair 
and the enriched residue positions in the PHD_nW_DD subtype. We examined the 
following two relationships first: (a) the enrichment in artificial sequences and (b) 
reciprocal enrichment. For the enrichment analysis, artificial PHD finger sequences were 
generated with E-values consistent with that of natural PHD sequences (Figure 3.11A) 
and with characteristics similar to that of the PFAM master alignment (Figure 3.10C). 
Enrichment analyses carried out with the artificial sequences clearly show that results 
differ from those observed with natural sequences (Figure 3.10B, right). For example, 
positive enrichment of the L2 position (p = 0.310.63) when the D2 position is 
perturbed in natural sequences is very different from the distribution of L2 position 
enrichment probabilities observed with artificial sequences for D2 perturbation (Figure 
3.10B, right). This observation suggests the nonrandom nature of the enrichment 
observed here. For reciprocal enrichment, we wanted to check whether the D2 position 
would similarly show positive enrichment (Δp > 0) if other nonpolar residue positions 
(e.g., the L2 position) were perturbed (Figure 3.9A). Asp was enriched at the D2 position 
when other peptide-anchoring positions were perturbed in natural sequences (Figure 
3.9A). Like the D2 positions, other peptide-anchoring positions were also checked to 
determine whether there is a mutual relationship among a set of positions in the PHD 
superfamily fold (Figures 3.9A, 3.7D).   
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          Although enrichment analysis is simple with respect to computation, it may lack 
mathematical rigor and be unable to distinguish stochastic relationships from real ones. 
Therefore, we applied mutual information (MI) theory to probe the relationship between 
the peptide-binding positions of PHD fingers. This was motivated by the earlier 
observation that a set of PDZ peptide binding-site positions (5–6 positions) was observed 
to have higher MI, and these residues were concluded to be coevolving45. Using the 
MISTIC89 server, we estimated the MI for every residue pair in the PHD PFAM 
alignment positions (Figure 3.9B). Many of the residue pairs showing mutual enrichment 
(Figure 3.9A) have MI scores that are much higher than the rest of the PHD residue pairs 
(Figure 3.9B). The MI behavior of PDZ-binding residues was also estimated (Figure 
3.22A) for comparison. Despite differences in the construction of the dataset and 
approach from the earlier study45, it was interesting to observe that residue pairs 
consisting of only 5–6 positions (Figure 3.22A) show MI values well above the rest, as 
reported earlier. Our approach is thus acceptable, and the MI behavior of enriched PHD 
binding-site residues is comparable to that of the PDZ domain (Figure 3.22A). It is 
therefore tempting to believe that PHD binding-site residues (at the L2, D2, G/W, AP2 
positions) are also coevolving like the PDZ binding site45. With regard to coevolving 
binding-site residues, the similarity between the PHD and PDZ domain can further be 
appreciated by considering the following. Like ADD redesign (for switching peptide 
specificity)28, 29, desirable substitutions at the coevolving PDZ binding-site positions can 
also switch peptide specificity: e.g., in redesigning Tiam1 to behave like Tiam2114. Thus, 
identification of coevolving positions can also be useful for subtype switching.  
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          Cumulative MI (CMI), reported by the MISTIC89 server, represents the degree of 
participation of a position in the mutual information network91. For the PHD finger, the 
W/G position has the highest CMI value (Figure 3.9B), as the position shows a strong 
negative enrichment compared with many other nonpolar residue peptide-anchoring 
positions (Figure 3.9A), and the W/G position also shows a positive enrichment for 
aromatic cage residues7. Therefore, using the W/G position to partition the PHD finger 
sequences as a first step in PHD subtype analysis (see Figure 3.15) is justified. The L2 
position also has a large CMI value, suggesting its contribution in PHD subtype 
classification. However, artificial PHD sequences (see above) do not show a positional 
correlation (Figure 3.11B, C).   
 
Figure 3.22. Mutual Information of the PDZ binding site: (A) MI score of PDZ binding-site positions 
(right) with the residues mapped on the INAD_DROME PDZ structure (left). Only 18 binding-site 
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positions (left) mapped on the structure are analyzed for MI (right). Seven positions with higher inter-
residue MI value are indicated in gray on the structure (left, e.g. S27, F28, I30 etc.) and their MI values are 
indicated with ‘¯’ arrow on the MI histogram. Protein name and pdb id are indicated. (B) A part of the 85% 
non-redundant PFAM alignment of PDZ domains used for MI calculation shows the positions of the seven 
binding site positions for convenience. The double-headed arrows indicate interacting positions. (C) 
Reciprocal enrichment for some of the selected binding-site positions.  
 
GREMLIN distance restraints and RMSD 
          Mutual information extracted from multiple alignments to infer coevolution by 
correlated mutation has recently been successful in protein structure prediction87, 88, 115, 
116. In other words, the correlation between alignment positions can provide distance 
restraints for folding the polypeptide chain representing a protein family87, 88, 115, 116. The 
PHD finger binding-site positions that we found to be correlated are likely to be 
correlated for biochemical function (e.g., peptide binding) rather than for the folding of 
the PHD scaffold. With GREMLIN87, 88 pre-computed distance restraint scores for PFAM 
domain residue pairs, we wanted to check the scores of PHD finger positions that are 
related by function (e.g., L2–D2 or L2–W pair positions, Figure 3.9B). GREMLIN 
distance restraint scores for these functionally related positions are actually observed to 
be much higher than the rest of the pairs (Figure 3.9B), even though these residues are 
not in van der Waals contact with each other. Physically interacting positions that 
contribute to folding are expected to coevolve as a mechanism for compensating the 
replacement of interacting partner residues. In the PHD example, the restraint score does 
not seem to distinguish between pairs physically interacting with one another from those 
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related by function. The pre-computed GREMLIN score therefore, encouraged us to 
experimentally probe the roles of the correlated binding-site positions by mutagenesis.  
A comparison of the RMSD of crystal structures (≤ 2.2 Å) of PFAM domain members 
sharing less than 40% sequence identity shows that the structural deviation of the PHD 
peptide binding-site is smaller (Figure 3.23B). The implication is that this smaller 
structural deviation may be useful in design applications. The introduction of desired 
substitutions at coevolving binding-site positions would likely confer small structural 
perturbations and thus enable achieving the expected outcome without having to carry out 
extensive optimization of the rest of the scaffold, e.g., repurposing of the ADD  
module28, 29.  
          Here we were also able to enhance the affinity of the AIRE PHD (~15-fold lower 
Kd) by merely incorporating a desired substitution at a coevolving position showing a 
very small structural deviation (e.g., L2 in Figure 3.23C). In addition to altering affinity 
and specificity, sequence-based subtype classification can also benefit from the observed 
small structural deviation. As the rest of the PHD sequence positions show larger 
structural deviations (Figure 3.23B), inclusion of non-binding site sequence positions in 
subtype classification may not provide reliable groupings. For example, an earlier 
study117 on PHD finger classification, using the full-length PHD sequence had grouped 
BAZ2A (and BAZ1A, BAZ1B, BAZ2B) with AIRE (and TIF1A, CHD3_1, CHD3_2, 
PF21A), while MYST DPFs were placed in a separate group. As observed in an earlier 
work7, the binding behavior of BAZ2A, a PHD_nW_DD subtype, is distinct from that of 
AIRE, and we found that DPF binding behavior is similar to PHD_nW_DD. Thus, our 
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experiments suggest that grouping based on a set of coevolving binding-site residues, 
especially showing small structural deviations, would likely be more reliable.   
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Figure 3.23.  GREMLIN score and RMSD of peptide binding sites: (A) GREMLIN s-sco score mapped on 
to the structure of PHD (left), PDZ (middle) and Bromodomain (right). (B) Structural deviation (RMSD) 
between corresponding positions among X-ray structures (resolution ≤ 2.2Å) of a superfamily sharing less 
than 40% sequence identity. The color ranges between black (RMSD = 0.0 Å) to white (RMSD = 3.5Å). 
PHD positions are indicated on the structure. (C) Mean and SD of the corresponding position’s Cα-Cα 
atom distances for the binding- site coevolving positions. (D) Alignment between GREMLIN consensus 
sequence and the protein sequence is presented for the convenience of mapping the s_sco score on the 
structure. 
 
Characteristics of Arg-rich peptide recognition 
          Histone peptides are rich in positively charged residues, and therefore the 
observation of enriched nonpolar residues making significant energetic contributions to 
histone peptide recognition encouraged us to further determine the recognition 
characteristics of peptides rich in Arg and Lys residues. Using Rosetta alanine-scanning 
mutagenesis96 on the dataset of peptide−protein complexes used in an earlier work7, we 
computationally probed peptide-recognition characteristics. Peptide hotspot propensity 
scores computed using this dataset also show strong preferences for W, F, I, L, Y, and R 
(propensity score > 1.0), and some of the remaining (disfavored) amino acids have scores 
<0.75 (Figure 3.12B). Therefore, for the analysis we focused on peptide Arg hotspot 
residues (Figure 3.12B). ARG-Nearness, the preference of an amino acid to be adjacent 
(± 2 positions) to the peptide Arg hotspot residue was also computed (Figure 3.12B). The 
ARG-Nearness propensity score is quite different from that of the reference peptide 
hotspot scores (Figure 3.12B). For example, irrespective of side chain size, the ARG-
Nearness propensity scores of several amino acids are close to 1 (Figure 3.12B); i.e., 
amino acids with even small side chains (e.g., G, A, or T) are thus not disfavored to be 
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near an Arg hotspot residue in peptide−protein complexes. This is important, as the 
presence of amino acids with small side chains adjacent to Arg residues is common 
among histone-tail sequences. For comparison, Arg in the kinase-docking D motifs is 
close to one or more bulky nonpolar residues118, 119. Therefore, to better understand 
nature’s design principles, we wanted to know whether there is a preference for amino 
acids (at the peptide binding site of a protein, e.g., L1 or L2) for making contact with 
residues with small side chains adjacent to peptide Arg hotspot residues (Figure 3.12C).       
          Hotspot propensity scores of protein residues (Figure 3.12C) also showed that 
bulky nonpolar amino acids dominate the residue preferences. This is also consistent with 
our observations for several histone/histone-like peptide complexes (Figure 3.12D) that 
bulky nonpolar residues at the binding site establish contacts with the small-volume 
residues adjacent to the peptide Arg hotspot residue. Therefore, the mechanism of having 
bulky residues at the L1 and L2 positions for contacting Ala and Thr of the H3 peptide 
adjacent to the hotspot R2 residue is likely to be a well-tested natural mechanism, and 
therefore the same strategy could be implemented in designing diagnostic proteins to 
target site-specific Arg residues of histone tails. Grafting a complementary peptide 
segment onto an antibody scaffold has shown promise for targeting specific peptide 
segments within intrinsically disordered segments120. Our observations on nonpolar 
residues could thus be useful for such a strategy for targeting intrinsically disordered 
unmodified histone peptide segments.  
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CHAPTER IV 
GENERAL DISCUSSION AND CONCLUSION 
          Next-generation sequencing efforts on diagnosed patient genomes or cancer tissues 
now show that aberrations (mutations or overexpression) in proteins harboring the 
PHD_nW_DD subtype are associated with different pathological consequences (Figure 
4.1). Therefore, as a first step toward eventual comprehension of the possible 
mechanisms underlying pathological consequences, detailed characterization of the 
binding mechanism of the PHD_nW_DD subtype was undertaken here. Starting with one 
member (BAZ2A PHD) of the subtype, key histone peptide-anchoring residue positions 
were first identified by mutagenesis. Loss of interfacial packing due to residue 
substitution contributes to the observed binding energetics. Interestingly, the peptide-
anchoring residue positions (ΔΔG ≥ 1.0 kcal/mol) of the BAZ2A PHD are enriched in 
specific types of residues in a subtype-specific manner. The energetic contributions of the 
identified positions were further confirmed by mutagenesis in three other members of the 
subtype (UHRF1, KDM5B, KAT6A), which included pairs sharing <40% sequence 
identity with each other. Despite low sequence similarity, mutations cause similar 
consequences in histone H3 binding, suggesting a strong similarity in the binding 
mechanism and thus supporting the classification of the subtype. 
          The positions of peptide-anchoring residues of the PHD_nW_DD subtype are also 
mutually correlated, while corresponding positions in artificial PHD sequences (E-value 
≤ 10-5) are not. Based on our experimental observations, it is thus temping to believe that 
the correlation is for biochemical function (peptide binding) rather than for folding. The 
three-dimensional distances between two correlated positions in a protein sequence 
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predicted by powerful computational approaches87, 88, 115, 116 can thus be complemented 
by a systematic mutagenesis approach to dissect the true origin of the correlation, 
particularly for positions at the functional site. Like the coevolving binding-site residues 
of the versatile PDZ domain, the correlated binding-site residues of the versatile PHD 
finger are also coevolving. The positions of some of the coevolving residues show very 
small structural deviations among diverse sequence homologs, and this observation will 
be useful for redesigning the PHD binding site for enhancing affinity and switching 
specificity. The binding mechanism of the PHD_nW_DD subtype likely originated early 
to anchor residues 1–3 of histone H3. This mechanism features the characteristic treble 
clef knuckle Asp residues for anchoring the peptide Arg hotspot, while the acidic patch 
residues contribute to the helical conformation of N-terminal histone H3. A set of 
nonpolar amino acids is among the residues enriched in the PHD_nW_DD subtype, and 
these nonpolar amino acids tightly pack against the peptide residues with small side 
chains present on either side of the peptide hotspot Arg residue. This strategy of 
employing tightly packed, bulky nonpolar residues to anchor residues with small side 
chains adjacent to the peptide hotspot can be useful for histone diagnostic design. In 
general, the lessons learned from the current study will be useful in the functional 
characterization of large protein families. 
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Figure 4.1. Human disorders associated with PHD_nW_DD: Kebuki syndrome105-108, diffuse large B-cell 
lymphoma (DLBCL)108, colorectal109, gynecological carcinoma110, intraocular medulloepitheliomas19, non–
small cell lung cancer (NSCLC)111 mutations respectively are colored in gray, pink, green, yellow, cyan, 
split pea, and the upward arrow ‘↑’ indicates increase in protein expression in prostate112 and ovarian113 
cancer. Protein names are on the left and star ‘*’ denotes nonsense mutations. PHRF1 is included here for 
recent reports on the association of the tumor suppressor role of PHRF189, 114. All these mutations are taken 
from the references cited in above, and for convenience only selected proteins and their PHD_nW_DD 
mutations (among other mutations) are listed here. 
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